nct_id,drug,target,toxicity_profile,hepatotoxicity_rate,cardiotoxicity_rate,neurotoxicity_rate,immunotoxicity_rate,cytokine_release_rate,infusion_reaction_rate,overall_safety_score
NCT00000000,Trastuzumab,HER2,cardiotoxicity,0.03230123987928382,0.10327030729532827,0.02315477556400669,0.05723013017622783,0.16928591317112884,0.22974879478312843,0.8975014731884827
NCT00000001,Bevacizumab,VEGF,vascular,0.08862968168611018,0.04470317949000957,0.0761982102195864,0.11490722506600184,0.03646723098869169,0.1195121171255887,0.9199303925706686
NCT00000002,Daratumumab,CD38,infusion_reactions,0.06471139367792304,0.0453344049475868,0.07019388472284487,0.05748241959061354,0.27853280402164177,0.368700056320822,0.8525075061197613
NCT00000003,Rituximab,CD20,infusion_reactions,0.07805810830867664,0.02271133178871705,0.032408498628963,0.06971232522253672,0.26054503842284416,0.39946038736936995,0.8561840517098154
NCT00000004,Bevacizumab,VEGF,vascular,0.14863636030568303,0.047911352148155215,0.023650194703089905,0.05080515122605503,0.07229996155640016,0.14571437954236177,0.9184971000863759
NCT00000005,Daratumumab,CD38,infusion_reactions,0.06187724360759693,0.02140147656733879,0.05505666259550598,0.13561030669194363,0.2975909531185731,0.5646572573833819,0.8106343500059433
NCT00000006,Ipilimumab,CTLA-4,immune_related,0.09265487283213963,0.06891500046610645,0.05222486319363605,0.36874885752827,0.23360689659046185,0.055868036677006475,0.8546635787853966
NCT00000007,Cetuximab,EGFR,skin_toxicity,0.1002685932984808,0.01625087031938435,0.020463179955508733,0.16445239078040566,0.1357205871355513,0.11866838655842403,0.9073626653253741
NCT00000008,Bevacizumab,VEGF,vascular,0.11551691910934019,0.046030990832887954,0.07120952215200273,0.07637143901651612,0.11797130351909729,0.14833187292971428,0.9040946587400736
NCT00000009,Cetuximab,EGFR,skin_toxicity,0.10750397144075746,0.05091235670745594,0.10335395440847191,0.1940874550035963,0.03942607145676093,0.14347652073521866,0.8935399450412898
NCT00000010,Ipilimumab,CTLA-4,immune_related,0.1426965502307679,0.01205017272890363,0.02382673908797296,0.10311880813256148,0.07102713881960565,0.09842885605401036,0.9248086224910297
NCT00000011,Daratumumab,CD38,infusion_reactions,0.0718839020668179,0.027427298494083062,0.02191340167940535,0.06911596933313303,0.28045529695195254,0.34755181317373396,0.8636087197168123
NCT00000012,Trastuzumab,HER2,cardiotoxicity,0.0732016408266804,0.3968695089331449,0.047364414241385835,0.08944118979721724,0.08895315365864262,0.2069888070867601,0.8495302142426948
NCT00000013,Trastuzumab,HER2,cardiotoxicity,0.01775625179231343,0.3841434582418727,0.013001687009253242,0.046346317939711563,0.1419125949497832,0.21249710526996324,0.8640570974661838
NCT00000014,Adalimumab,TNF-alpha,infection,0.047787687613167436,0.025330476710477896,0.025153965832142914,0.10292487726794375,0.04020619311253151,0.2654737248048214,0.9155205124431525
NCT00000015,Trastuzumab,HER2,cardiotoxicity,0.06271243788964391,0.3663395237553575,0.048633450536572066,0.053063513420166755,0.11701696105476683,0.07447466182971552,0.8796265752522963
NCT00000016,Tocilizumab,IL-6,infection,0.0838624499266839,0.062009625010292335,0.08273958730631635,0.19574290149284518,0.07150581809597488,0.23271614514795375,0.8785705788366556
NCT00000017,Bevacizumab,VEGF,vascular,0.04161627257504993,0.03374308302222325,0.042585760714500785,0.034902969327134964,0.10936243752901803,0.26821808301354993,0.9115952323030871
NCT00000018,Daratumumab,CD38,infusion_reactions,0.06935326999606255,0.03941073115344747,0.024412386407312414,0.05780167287226349,0.2943530417898383,0.2241067713870867,0.8817603543989981
NCT00000019,Cetuximab,EGFR,skin_toxicity,0.011837934954984884,0.029452192128699525,0.10003625886407959,0.05382513737511786,0.03672555487209575,0.10216536450012663,0.944326259550816
NCT00000020,Tocilizumab,IL-6,infection,0.09267323394584917,0.05748801742682948,0.10443047176651278,0.1568878325074065,0.06989206875385326,0.16350549134479714,0.8925204807091253
NCT00000021,Tocilizumab,IL-6,infection,0.031559849520720364,0.05540602683655503,0.11055377911259723,0.059381269551854604,0.07818300531575172,0.29376617083778955,0.8951916498041219
NCT00000022,Bevacizumab,VEGF,vascular,0.13150023018469606,0.056211763831018405,0.09580231654660805,0.053831625076793704,0.06445414951216456,0.09104908124779536,0.9178584722668206
NCT00000023,Cetuximab,EGFR,skin_toxicity,0.0530005491764042,0.08828482420706604,0.0813221258761516,0.04651215212771104,0.16019139779469177,0.23625649830363538,0.8890720754190566
NCT00000024,Pembrolizumab,PD-1,immune_related,0.0860843692160263,0.07258686380281505,0.034962381283495825,0.10857587488645408,0.18237710078192565,0.11789613740737381,0.8995862121036515
NCT00000025,Ipilimumab,CTLA-4,immune_related,0.0898368087988267,0.0748849403748013,0.026725341292874117,0.22944209101512886,0.0801240092470169,0.125328558792377,0.8956097084131626
NCT00000026,Tocilizumab,IL-6,infection,0.0811097553873325,0.014784136486952407,0.03998477533963229,0.03760628557834171,0.1237794797212154,0.23300040239099407,0.911622527515922
NCT00000027,Trastuzumab,HER2,cardiotoxicity,0.039581186052972187,0.18820176837470298,0.026107684128476707,0.0675239332174812,0.1294344130241664,0.14872324543985493,0.900071294960391
NCT00000028,Pembrolizumab,PD-1,immune_related,0.11503480126245084,0.05768123674013467,0.07170758858260169,0.3876915151873592,0.0939159529137431,0.05797066565050757,0.8693330399438671
NCT00000029,Ipilimumab,CTLA-4,immune_related,0.05535319362792801,0.028632477124882483,0.0252677908731292,0.1303095972734529,0.09529300314575476,0.1430331111321363,0.9203518044704527
NCT00000030,Ipilimumab,CTLA-4,immune_related,0.15737349771472747,0.03743356628344938,0.02810434175723093,0.3201773118020639,0.22590553416562648,0.09024004246499948,0.8567942843019838
NCT00000031,Daratumumab,CD38,infusion_reactions,0.0285134838178204,0.04142910605775579,0.03433431792693544,0.07879925497312348,0.21926267935034427,0.4935529083106126,0.850684708260568
NCT00000032,Daratumumab,CD38,infusion_reactions,0.018481831004150906,0.03012960610025598,0.05903298589250657,0.09767583291164841,0.16106483765328516,0.5626671066520688,0.8451579666310141
NCT00000033,Adalimumab,TNF-alpha,infection,0.043406727938596595,0.03836012491084504,0.017640009733520447,0.053721994160025974,0.1639790754976467,0.08545841381371584,0.9329056089909415
NCT00000034,Rituximab,CD20,infusion_reactions,0.011146134510210334,0.028984027632451816,0.033383790488972366,0.06775150520680163,0.15276643765160072,0.23079082718707655,0.9125295462204811
NCT00000035,Daratumumab,CD38,infusion_reactions,0.07112826480286917,0.04412358671716865,0.05158036086447578,0.1469541530861185,0.21663177162558805,0.39532293639546195,0.8457098210847196
NCT00000036,Daratumumab,CD38,infusion_reactions,0.032275938634061384,0.014375439895742092,0.06732485071731625,0.10672667300704586,0.2980826203385868,0.5341436124690999,0.8245118108230246
NCT00000037,Pembrolizumab,PD-1,immune_related,0.12879037764275053,0.021711331627141485,0.03172663675263914,0.12817302964626057,0.11092045426948759,0.1604279693242282,0.9030417001229154
NCT00000038,Blinatumomab,CD19/CD3,neurotoxicity,0.07336628935257089,0.0761333503691129,0.11887724302730453,0.06632111221114943,0.09783893019382577,0.1410723329684711,0.9043984569795942
NCT00000039,Adalimumab,TNF-alpha,infection,0.011898547529316891,0.041736374028787486,0.08811728661292251,0.18044703493423453,0.14392420728675964,0.26423904013843785,0.8782729182449235
NCT00000040,Ipilimumab,CTLA-4,immune_related,0.18532502410228974,0.05170204783905178,0.02902088539000597,0.30573524725282697,0.1956431085464363,0.053109091685601,0.863244099197298
NCT00000041,Trastuzumab,HER2,cardiotoxicity,0.07850462063195054,0.35687965725419435,0.03637467652383061,0.031330650065657134,0.12467483471807615,0.09887356099126368,0.8788936666358379
NCT00000042,Daratumumab,CD38,infusion_reactions,0.07669111864732613,0.04893162352762238,0.035159394997667716,0.12443651191091089,0.13876842248536236,0.5819257628255434,0.8323478609342612
NCT00000043,Bevacizumab,VEGF,vascular,0.0994227254026415,0.09689077544698975,0.10648584394870764,0.1421842746293914,0.16387542118119053,0.1623173366996118,0.8714706037819112
NCT00000044,Cetuximab,EGFR,skin_toxicity,0.1441628575522676,0.057421619115365315,0.039184026644647166,0.1422319452672609,0.16207918445014435,0.14775655640130458,0.8845273017615016
NCT00000045,Trastuzumab,HER2,cardiotoxicity,0.0392106000048567,0.3981831124639075,0.022372931894830663,0.02328799818725397,0.12801165994461883,0.11865488862122829,0.8783798014805507
NCT00000046,Tocilizumab,IL-6,infection,0.0957314401657475,0.04901136608108849,0.06005304412791778,0.194267546405305,0.1467744819486115,0.12210213338991734,0.8886766646469021
NCT00000047,Ipilimumab,CTLA-4,immune_related,0.19542048350908037,0.044924891329603735,0.07484213599391644,0.23989524173942894,0.08004555035112226,0.19500072034796528,0.8616451627881472
NCT00000048,Rituximab,CD20,infusion_reactions,0.06614156201655176,0.03657281284409965,0.031255191967470466,0.0788259953741852,0.2599570129733186,0.20623695985632595,0.8868350774946747
NCT00000049,Tocilizumab,IL-6,infection,0.015733433145474957,0.03547155688920881,0.07523787799163113,0.029574790804877574,0.068931440121043,0.15758070713329225,0.9362450323190787
NCT00000050,Adalimumab,TNF-alpha,infection,0.10243546408992563,0.010057754028522844,0.03765768092236717,0.08303928239770217,0.06532248590619956,0.26475263592227033,0.906122449455502
NCT00000051,Ipilimumab,CTLA-4,immune_related,0.1497988998426396,0.06382197647729843,0.032402961226514135,0.12580103959112712,0.1041337790230576,0.19938713841108957,0.887442367571379
NCT00000052,Cetuximab,EGFR,skin_toxicity,0.037541837844901595,0.06267023528101583,0.01887897321573065,0.05939439777869435,0.09570844284645887,0.13865805947916304,0.9311913422590059
NCT00000053,Cetuximab,EGFR,skin_toxicity,0.1236392724140736,0.06733401838512476,0.0564819616370089,0.1940432267095842,0.03570219146374898,0.11531522780692972,0.9012473502639217
NCT00000054,Blinatumomab,CD19/CD3,neurotoxicity,0.05228317174006574,0.037966222059705686,0.07202983728006325,0.14220617799213403,0.07159678435847788,0.19454185429807075,0.9048959920452471
NCT00000055,Rituximab,CD20,infusion_reactions,0.07149890653110617,0.017980266585952177,0.0194983526255329,0.10542837694251772,0.16021245316415442,0.23423917084137838,0.8985237455515597
NCT00000056,Bevacizumab,VEGF,vascular,0.08933311261085129,0.06654869445788782,0.070041374341927,0.08767386988426024,0.16014743665916006,0.15922320391245615,0.8945053846889096
NCT00000057,Pembrolizumab,PD-1,immune_related,0.07079148127873025,0.04093309319458408,0.04506083697308014,0.38046394441685816,0.19251970105999555,0.12025683114773837,0.8583290186548356
NCT00000058,Blinatumomab,CD19/CD3,neurotoxicity,0.06987368393925843,0.04784550984598862,0.05512844868556588,0.024981128903184026,0.10942545655539289,0.2893729384369584,0.900562138938942
NCT00000059,Blinatumomab,CD19/CD3,neurotoxicity,0.06892860704943579,0.07802708098778653,0.07767294056529823,0.07443019734020363,0.0588233048681288,0.1780516989028289,0.9106776950477197
NCT00000060,Trastuzumab,HER2,cardiotoxicity,0.01890924024181278,0.2629808654634187,0.03262298401528753,0.043467454942188274,0.1633002760020353,0.1285318644731281,0.8916978858103549
NCT00000061,Blinatumomab,CD19/CD3,neurotoxicity,0.06641189764299311,0.010535756138359774,0.09882291290111471,0.17748395706148065,0.09363532047176128,0.06358655855927446,0.9149205995375027
NCT00000062,Rituximab,CD20,infusion_reactions,0.014922347920505218,0.04319577157085345,0.055491595845620516,0.08334834545429028,0.11947981241634507,0.3162307696504694,0.8945552261903194
NCT00000063,Cetuximab,EGFR,skin_toxicity,0.07740550604971501,0.03981768368026817,0.016695124680986214,0.15328512910925707,0.12790607990124328,0.23484085559277118,0.8916749368309599
NCT00000064,Cetuximab,EGFR,skin_toxicity,0.017422837303729146,0.02845580046224417,0.025856709046851223,0.15327634136460813,0.09924874441194861,0.10588589589121254,0.9283089452532344
NCT00000065,Adalimumab,TNF-alpha,infection,0.10459530658687305,0.08670301261491921,0.04309814295996979,0.07596034921292638,0.1782653807837143,0.05161270015987911,0.9099608512802864
NCT00000066,Tocilizumab,IL-6,infection,0.07789372017467727,0.07189972272562227,0.02261797500689049,0.02000642811912279,0.1166065059660662,0.08025860436227648,0.9351195072742241
NCT00000067,Daratumumab,CD38,infusion_reactions,0.018717727305356764,0.018171746165635293,0.04316196822915931,0.1332726452542875,0.18876317499684375,0.22226126469982993,0.8959419122248146
NCT00000068,Pembrolizumab,PD-1,immune_related,0.06827171217641653,0.038319013520034896,0.09861570130827661,0.3460812871938822,0.21834416068751855,0.13200788713276929,0.8497267063301837
NCT00000069,Bevacizumab,VEGF,vascular,0.12503610421558026,0.07131884023190802,0.10452452765701356,0.13108853326868547,0.08917659180908961,0.20904929120402388,0.8783010186022832
NCT00000070,Ipilimumab,CTLA-4,immune_related,0.07772117794493531,0.06729850703568678,0.07259722902815455,0.151232647549022,0.19833294406477908,0.1320021538440336,0.8834692234222314
NCT00000071,Cetuximab,EGFR,skin_toxicity,0.07666217585850732,0.03610325698592076,0.08342890822143975,0.19263645459694775,0.09887426181714463,0.21692491485771043,0.8825616712770549
NCT00000072,Tocilizumab,IL-6,infection,0.06476649086188456,0.07278874331703013,0.021806942306727212,0.09504136433026827,0.08797327297707382,0.05699266471606161,0.9334384202484924
NCT00000073,Pembrolizumab,PD-1,immune_related,0.11856234198822807,0.049494635889381605,0.02088157151969556,0.19082847096193628,0.17902179755333414,0.18398314601614119,0.8762046726785472
NCT00000074,Trastuzumab,HER2,cardiotoxicity,0.053391352378678,0.11278953904235733,0.04628233741364684,0.09702372201639624,0.1201860661235722,0.19461305358760084,0.8959523215729581
NCT00000075,Trastuzumab,HER2,cardiotoxicity,0.02938328274070027,0.39452610572795843,0.024309906512689106,0.08846716574491392,0.12548084319842623,0.11976681635163802,0.8696776466206123
NCT00000076,Pembrolizumab,PD-1,immune_related,0.15593369252054654,0.03734370280737549,0.025021261676846072,0.2967757742510797,0.12037340053310004,0.15788136634582406,0.867778466977538
NCT00000077,Tocilizumab,IL-6,infection,0.0575007507527429,0.07436640998184495,0.09653665539178492,0.07010122598180896,0.14201721389108174,0.12573247127882564,0.9056242121203185
NCT00000078,Daratumumab,CD38,infusion_reactions,0.045453585655532106,0.04664640094021723,0.055159380390212884,0.08765227344822511,0.19435046256459027,0.46358872407786406,0.8511915288205597
NCT00000079,Daratumumab,CD38,infusion_reactions,0.061843505902327726,0.04709648981898434,0.06427785989734051,0.10254339073540718,0.12588439389730796,0.32963064488426475,0.8781206191440613
NCT00000080,Adalimumab,TNF-alpha,infection,0.14372724355236782,0.04132856981906586,0.07792225264972066,0.09267929339530018,0.027188661133673,0.26300779605820307,0.8923576972319449
NCT00000081,Daratumumab,CD38,infusion_reactions,0.02432617068926534,0.01386161764420896,0.017435430474284086,0.1434233908946233,0.19528260130235459,0.5039637125478225,0.8502845127412402
NCT00000082,Ipilimumab,CTLA-4,immune_related,0.19719925944329425,0.06659888382411583,0.0786117641899615,0.1709851557882841,0.22995886188858067,0.07609969384390469,0.8634243968369765
NCT00000083,Bevacizumab,VEGF,vascular,0.1349461991620934,0.07802324866949599,0.05620617718593283,0.031586582445701915,0.11790457993803483,0.0786184456896377,0.9171191278181838
NCT00000084,Adalimumab,TNF-alpha,infection,0.1285522593929685,0.016559352500271497,0.09396871448438936,0.12917599419975972,0.15450869682962828,0.2808877113723517,0.8660578785367719
NCT00000085,Adalimumab,TNF-alpha,infection,0.05496229004168912,0.07288531534713406,0.05153918403874211,0.19799675550111562,0.11180474586065796,0.09993360712326681,0.9018130170145657
NCT00000086,Pembrolizumab,PD-1,immune_related,0.08787424134958872,0.04062603978454643,0.04288714660733731,0.16035782264654466,0.08241791640827507,0.17207566111743017,0.9022935286810463
NCT00000087,Daratumumab,CD38,infusion_reactions,0.08278049961552307,0.017691832508450238,0.050747556252010266,0.11291156631695652,0.2337316499593945,0.28141584406268355,0.8701201752141636
NCT00000088,Trastuzumab,HER2,cardiotoxicity,0.0667006193089439,0.3679873034475065,0.024382440082545774,0.05264218960302772,0.131987126392675,0.06439302316414015,0.8819845496668601
NCT00000089,Daratumumab,CD38,infusion_reactions,0.0266773920611479,0.039199084626955864,0.07376919501259808,0.11422323772918767,0.19923509387692345,0.5329611635430895,0.8356558055250163
NCT00000090,Ipilimumab,CTLA-4,immune_related,0.13555551040274175,0.043161300905492306,0.04816848418503117,0.28554365910535107,0.16173946239564063,0.07068103045403498,0.8758584254252847
NCT00000091,Rituximab,CD20,infusion_reactions,0.01604392110928167,0.02710046995445213,0.03632827588303673,0.057086761719847036,0.11562876124261674,0.5129549429334606,0.8724761445262175
NCT00000092,Tocilizumab,IL-6,infection,0.05175177763497695,0.020613474584252403,0.03536308561014153,0.1282681253351036,0.07294716718499956,0.10600530620911679,0.9308418439069015
NCT00000093,Trastuzumab,HER2,cardiotoxicity,0.07584322631577219,0.376681998733018,0.020055273887642146,0.07626186511391711,0.06019292273272857,0.22429466718116853,0.8611116743392923
NCT00000094,Ipilimumab,CTLA-4,immune_related,0.1952172226697978,0.015234398599041,0.06602846994483376,0.3559585649917121,0.23636180998570822,0.12500705120590255,0.8343654137671674
NCT00000095,Pembrolizumab,PD-1,immune_related,0.10988294886646224,0.01396537392002279,0.07580143266428016,0.13326234128200826,0.14419574132103752,0.18760870060131024,0.8892139102241464
NCT00000096,Rituximab,CD20,infusion_reactions,0.033674776470593214,0.01119912118681512,0.03366316698117851,0.07608811050691548,0.1669082490921438,0.5058943660837172,0.8620953682797727
NCT00000097,Cetuximab,EGFR,skin_toxicity,0.02950040793860452,0.05923786128691297,0.09072599363518512,0.1863513672077809,0.12613378037490788,0.26956754487441575,0.8730805074470321
NCT00000098,Trastuzumab,HER2,cardiotoxicity,0.0264932041209106,0.12187357054426239,0.04791990386362559,0.09234590924382312,0.15546362456120938,0.20311484457178042,0.8921314905157314
NCT00000099,Bevacizumab,VEGF,vascular,0.014950690481203639,0.09829504382885007,0.11448985610743179,0.12766657317483493,0.11798922411127517,0.07014837206810458,0.9094100400380499
NCT00000100,Tocilizumab,IL-6,infection,0.08719953527322416,0.09519406088927247,0.03975592471336033,0.0275133758688794,0.02569601356577481,0.1769010663502757,0.9246233372232022
NCT00000101,Rituximab,CD20,infusion_reactions,0.06853032716753477,0.027260622524497687,0.0312392846100623,0.1349833502444996,0.29429312978350386,0.20857730487360518,0.8725193301327161
NCT00000102,Adalimumab,TNF-alpha,infection,0.01774991664059112,0.07962519184026144,0.0992499486474631,0.11615345500010998,0.1576471154444079,0.2204853040791956,0.8848481780579951
NCT00000103,Tocilizumab,IL-6,infection,0.11330929981569407,0.059724636401203283,0.015735445935902936,0.15782267278359088,0.131270485073611,0.1574296621630672,0.8941179663044885
NCT00000104,Rituximab,CD20,infusion_reactions,0.048415022339366696,0.015510817204589605,0.04065669982328623,0.13971467287514594,0.29650691137246976,0.3470834682935151,0.8520187346819378
NCT00000105,Pembrolizumab,PD-1,immune_related,0.07904684432945285,0.04055673811036946,0.024633800529343015,0.16961002742944092,0.16772349478311782,0.08406888292699921,0.9057267019818794
NCT00000106,Ipilimumab,CTLA-4,immune_related,0.16212135339442907,0.07218347368047723,0.08345446737779234,0.27041458348731634,0.24818774730230436,0.052234783999535225,0.8519005984596909
NCT00000107,Cetuximab,EGFR,skin_toxicity,0.1107757588847662,0.08313597027301438,0.018427284331858192,0.04280886097952767,0.04889495644878862,0.060929857034470666,0.9391712186745957
NCT00000108,Adalimumab,TNF-alpha,infection,0.058953444990055566,0.06896880567176807,0.03686687789700753,0.07263428988567683,0.1169798152420743,0.16967534135576862,0.9126535708262749
NCT00000109,Rituximab,CD20,infusion_reactions,0.021013872169652028,0.013072153352611622,0.02751391988758676,0.10436461955745589,0.1989858503718006,0.4940874511403585,0.8568270222534224
NCT00000110,Trastuzumab,HER2,cardiotoxicity,0.03498708198096463,0.37453025920411986,0.018811491561991522,0.07705070871276791,0.19121404815495052,0.2060416810980526,0.8495607882145255
NCT00000111,Adalimumab,TNF-alpha,infection,0.050975677979409176,0.06882794836147518,0.06795286065509641,0.06815634487118281,0.13164346997907062,0.17586135064135894,0.9060970579187345
NCT00000112,Cetuximab,EGFR,skin_toxicity,0.017559654776222722,0.09103828398119693,0.08760518427611871,0.1319369204902454,0.0647654152851654,0.10088873377451525,0.9177009679027559
NCT00000113,Bevacizumab,VEGF,vascular,0.029198408408459636,0.09783445653982122,0.03535895193772995,0.15354355856428906,0.05372314110129839,0.14309749626537926,0.9145406645305038
NCT00000114,Ipilimumab,CTLA-4,immune_related,0.17245695641779163,0.019937286246647958,0.0982327760667236,0.3095025817460062,0.1799816172781467,0.11806444781241378,0.8503040557387117
NCT00000115,Adalimumab,TNF-alpha,infection,0.02599340888098292,0.05490167413107506,0.013713180197275004,0.07003411953064223,0.08146826541473011,0.25679471262748627,0.9161824398696348
NCT00000116,Ipilimumab,CTLA-4,immune_related,0.06267399422048037,0.029536473749728474,0.06877981804843918,0.24860724960010158,0.22255456206588176,0.10769948748203338,0.8766914024722225
NCT00000117,Blinatumomab,CD19/CD3,neurotoxicity,0.016218177016249162,0.028515710861529618,0.030286947657107002,0.097595293639962,0.028361544204237997,0.12628701819350213,0.945455884737902
NCT00000118,Pembrolizumab,PD-1,immune_related,0.13123237501419668,0.03434631769065315,0.02207936818006873,0.28262178768473434,0.22863387217554193,0.18840480241346091,0.8521135794735574
NCT00000119,Trastuzumab,HER2,cardiotoxicity,0.07352147078795203,0.3430731060057544,0.033638345067663236,0.08058017732342788,0.10114165774634437,0.2158478910051741,0.8586995586772806
NCT00000120,Bevacizumab,VEGF,vascular,0.07077064142528115,0.04847942702796415,0.09021487476037675,0.15237460788661336,0.029138974913831585,0.07730255118253483,0.9219531538005663
NCT00000121,Rituximab,CD20,infusion_reactions,0.044929950652440064,0.038851881007096974,0.05745786674409579,0.13585140927947398,0.2875952147465368,0.38540101475666466,0.8416521104689486
NCT00000122,Blinatumomab,CD19/CD3,neurotoxicity,0.09016435742892939,0.061147274890624825,0.06708041473188309,0.04925879651945011,0.08100656565109786,0.23640846757704964,0.9024890205334942
NCT00000123,Cetuximab,EGFR,skin_toxicity,0.1394525594513995,0.02186854415904085,0.011670175499297775,0.16392600627890058,0.1721547571115408,0.07138421684281172,0.9032572901095015
NCT00000124,Pembrolizumab,PD-1,immune_related,0.08748989228681386,0.04799631894162107,0.04700258825485863,0.21838036113665896,0.1731094498548953,0.10425423003965693,0.8869611932475825
NCT00000125,Cetuximab,EGFR,skin_toxicity,0.10229219209456336,0.08041836588660478,0.0991285446649196,0.12943985165820301,0.03988902605401892,0.19211026888485339,0.8927869584594729
NCT00000126,Rituximab,CD20,infusion_reactions,0.03888904523283229,0.020580701782582006,0.022514907725651616,0.09627242685650786,0.18798185588251157,0.3865758002907149,0.8745308770382
NCT00000127,Blinatumomab,CD19/CD3,neurotoxicity,0.14522396899924658,0.05321871189323722,0.10287578635831866,0.05921164999566941,0.029373573755705727,0.28470856450413706,0.8875646240822809
NCT00000128,Daratumumab,CD38,infusion_reactions,0.034880110403403525,0.03441314087851282,0.03198185739465453,0.05640434879097306,0.1359607819587096,0.506390731891202,0.866661504780424
NCT00000129,Daratumumab,CD38,infusion_reactions,0.03485299083112681,0.04476221486774949,0.018905573605890007,0.11303381783850142,0.12938035707360382,0.44717972176068466,0.8686475540037406
NCT00000130,Blinatumomab,CD19/CD3,neurotoxicity,0.016941154394851204,0.02030019066418763,0.014235195594043307,0.14319944911606203,0.1576912444118367,0.1949726788649977,0.9087766811590036
NCT00000131,Daratumumab,CD38,infusion_reactions,0.013776002822866248,0.03869430787204278,0.014256900747263917,0.12145495637653107,0.15181095000398506,0.30297802989518097,0.8928381420470217
NCT00000132,Blinatumomab,CD19/CD3,neurotoxicity,0.10497429473914446,0.08717412767147019,0.048866854603950294,0.14929747349062525,0.11609261421525104,0.13743241263397687,0.8926937037742636
NCT00000133,Bevacizumab,VEGF,vascular,0.02084707998462998,0.04994314156611585,0.0662139069178665,0.06265616801923174,0.07212624737067926,0.14283984048131454,0.930895602610027
NCT00000134,Daratumumab,CD38,infusion_reactions,0.08404236489006477,0.02663878681403195,0.054932091905573556,0.13758531382909744,0.12861589644058732,0.3306162166803084,0.8729282215733895
NCT00000135,Bevacizumab,VEGF,vascular,0.12034302465945608,0.04014872065006863,0.05489513068432468,0.13735607823318846,0.09530960552987998,0.2933753000461739,0.876428690032818
NCT00000136,Trastuzumab,HER2,cardiotoxicity,0.05353414581850931,0.14809384577341805,0.01178442308034677,0.09442468115691141,0.18678089893373934,0.05510705725287213,0.9083791579973671
NCT00000137,Daratumumab,CD38,infusion_reactions,0.06481343313331282,0.042321368549199635,0.04575572997408925,0.12808737512085094,0.20163645414034598,0.43259459946405954,0.8474651732696903
NCT00000138,Bevacizumab,VEGF,vascular,0.058167384502228914,0.029338184774634034,0.10137994463812922,0.025867915140618973,0.13620156186827978,0.14527241580674766,0.9172954322115603
NCT00000139,Ipilimumab,CTLA-4,immune_related,0.19967312773601575,0.015491148061026295,0.02618491527952263,0.3806553609497535,0.09491620148033258,0.12552438303583818,0.8595924772429185
NCT00000140,Tocilizumab,IL-6,infection,0.09042149460498548,0.059340972721991035,0.05598881296281823,0.1519482189552756,0.15561521277246426,0.1819390997257187,0.8841243647094578
NCT00000141,Daratumumab,CD38,infusion_reactions,0.014628835355037307,0.028893166380881595,0.04671136495786547,0.09410174140106092,0.15383654414865908,0.5344035761810653,0.8545707952625717
NCT00000142,Adalimumab,TNF-alpha,infection,0.05102914324067333,0.0319626095859826,0.036738067700644236,0.15817581456859003,0.07791439322339379,0.163955293437124,0.9133707797072653
NCT00000143,Cetuximab,EGFR,skin_toxicity,0.11474635911088851,0.02038752274495796,0.03651511243694143,0.15190369943059637,0.16083628464928365,0.14047028995992628,0.8958567886112343
NCT00000144,Blinatumomab,CD19/CD3,neurotoxicity,0.05927784531164167,0.05550790985584214,0.11060990631470581,0.1375993869241164,0.11683497337144592,0.16224200536739852,0.8929879954758082
NCT00000145,Cetuximab,EGFR,skin_toxicity,0.06863903218632088,0.06124080288785621,0.10094623095200916,0.04255062659553475,0.10601854353540412,0.24411206787315332,0.8960821159949536
NCT00000146,Pembrolizumab,PD-1,immune_related,0.11114261598226258,0.05093287353674461,0.031051212314096487,0.17808368607429254,0.10737703791494935,0.09707665084074887,0.9040559872228175
NCT00000147,Adalimumab,TNF-alpha,infection,0.021410834023284836,0.04789203312585007,0.11815725256743909,0.12368211514470014,0.12122076258831171,0.24316124394182898,0.8874126264347642
NCT00000148,Blinatumomab,CD19/CD3,neurotoxicity,0.13598214555671959,0.08887651272763478,0.011706347676700375,0.04174199220055794,0.06214017959297842,0.18864469474438927,0.91181802125017
NCT00000149,Adalimumab,TNF-alpha,infection,0.14021752317086186,0.07685685931957947,0.023903774661127235,0.026133620367158494,0.08902717831603463,0.22251164124707806,0.9035582338196934
NCT00000150,Blinatumomab,CD19/CD3,neurotoxicity,0.14859068773852332,0.0219139979507084,0.10535679875481176,0.1853521405895095,0.16468166282458147,0.1385919428010527,0.8725854615568022
NCT00000151,Tocilizumab,IL-6,infection,0.06632445095159126,0.06012467027998822,0.08831818627024521,0.04142533585895218,0.16358821132745213,0.27458847302317707,0.8842717787147657
NCT00000152,Rituximab,CD20,infusion_reactions,0.06323302019229658,0.03466518375509137,0.0795893872570438,0.05452376982104223,0.2477496846329029,0.3419830529389353,0.8630426502337813
NCT00000153,Bevacizumab,VEGF,vascular,0.07284534787755004,0.04679872525315642,0.05947290861216726,0.17026484100836684,0.06628658265788563,0.1692765118556352,0.9025091804558731
NCT00000154,Bevacizumab,VEGF,vascular,0.028844775577500745,0.02651057008753472,0.09425512846448565,0.18494153251960196,0.1698594313971686,0.07094737282443118,0.9041068648548796
NCT00000155,Ipilimumab,CTLA-4,immune_related,0.18433987573659094,0.051548730071733745,0.04958991269702141,0.2948214280311625,0.12587491619652041,0.11578805615386621,0.8630061801855174
NCT00000156,Tocilizumab,IL-6,infection,0.0812134067800242,0.06292727898908378,0.11392449092142802,0.037441748394127464,0.06757576524411853,0.13527930276149502,0.9169396678182872
NCT00000157,Pembrolizumab,PD-1,immune_related,0.13461970074215268,0.07281111379536655,0.06638625652088397,0.3532196281732103,0.13533790601083218,0.09842001093633594,0.8565342306368697
NCT00000158,Adalimumab,TNF-alpha,infection,0.054600962147280795,0.026057423098506262,0.025751621683037178,0.1665176924326232,0.1375401197461893,0.29730134332736,0.8820384729275006
NCT00000159,Trastuzumab,HER2,cardiotoxicity,0.024747648240161204,0.25574049117771436,0.03300551291691772,0.06923819977901423,0.06491998025850834,0.10695819134353479,0.9075649960473582
NCT00000160,Ipilimumab,CTLA-4,immune_related,0.06778266164046878,0.029169395000223072,0.05511333955742917,0.3656047489553409,0.1076957642126156,0.18765395983244743,0.8644966884669125
NCT00000161,Tocilizumab,IL-6,infection,0.14843278039145338,0.07781219243668579,0.111696743782492,0.13995805017764246,0.04256050002095224,0.10171077801317617,0.896304825862933
NCT00000162,Daratumumab,CD38,infusion_reactions,0.08549109962420788,0.04019458954598082,0.011914508729334231,0.14025413024406508,0.29197134061253727,0.41593189995859836,0.8357070718808794
NCT00000163,Blinatumomab,CD19/CD3,neurotoxicity,0.12185888027637132,0.01059985960984923,0.10157549441206307,0.024639914978424462,0.05250255022267998,0.2854514895898844,0.9005619684851213
NCT00000164,Blinatumomab,CD19/CD3,neurotoxicity,0.08996312275313106,0.07588804766561255,0.06729832845836622,0.1695868067569501,0.06719065298795127,0.07740371919470075,0.9087782203638813
NCT00000165,Daratumumab,CD38,infusion_reactions,0.07356899799947834,0.04378976497648376,0.041108354421120756,0.09322659484539594,0.15261130643913717,0.545801100542599,0.8416489801292975
NCT00000166,Blinatumomab,CD19/CD3,neurotoxicity,0.14903081505733315,0.07584703683990539,0.022810890425207855,0.0836698092867091,0.03265073268923464,0.24833006378718048,0.8979434419857383
NCT00000167,Tocilizumab,IL-6,infection,0.1118306226313788,0.039440414414595414,0.06577661899393117,0.06969944537895567,0.12089983074131219,0.17821102826312457,0.9023570065961171
NCT00000168,Adalimumab,TNF-alpha,infection,0.11878637992123058,0.07361288213666067,0.04462909175567311,0.18645139654654438,0.08934041988901949,0.2830920001586968,0.8673479715986958
NCT00000169,Ipilimumab,CTLA-4,immune_related,0.16912960989918202,0.032226903910397786,0.0873144832600178,0.2983391281313487,0.22551470641207816,0.05534542793316678,0.8553549567423014
NCT00000170,Blinatumomab,CD19/CD3,neurotoxicity,0.09882960176333715,0.010717352942617503,0.02505621399356253,0.08771763024464746,0.1709059789421672,0.21833690776616016,0.898072719057918
NCT00000171,Bevacizumab,VEGF,vascular,0.047140046550453875,0.023628979575676057,0.09952557370499919,0.15204092330791616,0.06521594778512946,0.09964324205140158,0.9188008811707373
NCT00000172,Adalimumab,TNF-alpha,infection,0.13262095266893234,0.09557494823982984,0.10428724758000071,0.15490027575607623,0.020511633675478435,0.06681531684601892,0.9042149375389439
NCT00000173,Daratumumab,CD38,infusion_reactions,0.06019634451724252,0.01834187886416629,0.022468051781631193,0.09181593484281125,0.15261476280298564,0.3521160919398855,0.883741155875213
NCT00000174,Cetuximab,EGFR,skin_toxicity,0.09174585381791149,0.06739431643026575,0.06326563692354206,0.13824937397077933,0.04881029352890211,0.12502514280507687,0.9109182304205871
NCT00000175,Blinatumomab,CD19/CD3,neurotoxicity,0.04246506722648047,0.036290432513638005,0.06335659454706621,0.16341431180689445,0.08275360893945945,0.13928196792195235,0.9120730028407515
NCT00000176,Trastuzumab,HER2,cardiotoxicity,0.04366713367908601,0.12895996992050976,0.014494696844494026,0.09047161513377332,0.1632441652163155,0.10745427074967924,0.9086180247426904
NCT00000177,Bevacizumab,VEGF,vascular,0.14571070002469574,0.03928573416371392,0.08286600088130816,0.04084745237018911,0.09435774917163316,0.1297264886286349,0.9112009791266376
NCT00000178,Blinatumomab,CD19/CD3,neurotoxicity,0.02589508107797056,0.072727172269136,0.08753006811504337,0.15926272063546523,0.0973981974603186,0.25118032743038465,0.884334405501947
NCT00000179,Tocilizumab,IL-6,infection,0.07848441290965846,0.04708026268966477,0.035834604450955085,0.07236744246055406,0.10119798447502394,0.2724526532944075,0.8987637732866227
NCT00000180,Adalimumab,TNF-alpha,infection,0.1195959052239419,0.015472293500625772,0.09489785235785783,0.06708894551916442,0.07081893731502184,0.14784459845913672,0.9140469112707086
NCT00000181,Tocilizumab,IL-6,infection,0.07187321647649926,0.045881156053117995,0.11036056031293921,0.06829710205935664,0.1365098955857136,0.13496038920481912,0.9053529467179257
NCT00000182,Bevacizumab,VEGF,vascular,0.12459344183197611,0.03776595846032553,0.05507926973956901,0.12305102540263502,0.04664562289239538,0.10155020538634062,0.9185524127144598
NCT00000183,Adalimumab,TNF-alpha,infection,0.0975401107627465,0.09530900148408872,0.07746343685077617,0.07934315177246004,0.116793792891225,0.05497997915424137,0.9130950878474103
NCT00000184,Adalimumab,TNF-alpha,infection,0.11111202093181367,0.08221715900396505,0.019927798180637415,0.14685149371617923,0.16595657033050135,0.241710512649292,0.8720374075312686
NCT00000185,Adalimumab,TNF-alpha,infection,0.08740518665973147,0.06894384245894379,0.06705138983689973,0.0851775952904305,0.05175037024643098,0.08924822777164922,0.9250705646226524
NCT00000186,Adalimumab,TNF-alpha,infection,0.08499783363471684,0.08737505521330122,0.03522679151535498,0.1642313710529562,0.16570460483298294,0.13287552821151033,0.888264802589863
NCT00000187,Pembrolizumab,PD-1,immune_related,0.08234226467417682,0.06133340446210848,0.09520110369541698,0.1108224917474731,0.05400567465293676,0.19105327896016322,0.9008736303012874
NCT00000188,Ipilimumab,CTLA-4,immune_related,0.0653781095536418,0.0378556185617599,0.05879199566977332,0.1470836519071975,0.11029328707493001,0.08450078587780391,0.9160160918924822
NCT00000189,Blinatumomab,CD19/CD3,neurotoxicity,0.11813762885577829,0.03225778649032132,0.03997040705748419,0.042255709516549486,0.14544857785446252,0.21381898969551721,0.9013518167549812
NCT00000190,Adalimumab,TNF-alpha,infection,0.028367046524296877,0.07664731628370246,0.0396998527259991,0.035284993304125024,0.03182243884147365,0.2305282173743271,0.9262750224910127
NCT00000191,Cetuximab,EGFR,skin_toxicity,0.11673403890855187,0.047384202121301566,0.011621596229759728,0.16944527341057086,0.11677949776527234,0.08796188923633967,0.9083455837213673
NCT00000192,Pembrolizumab,PD-1,immune_related,0.16038100971452424,0.06548340042962635,0.03554272641627294,0.2817074742748657,0.11243794081326092,0.09855900975892623,0.8743147397654206
NCT00000193,Trastuzumab,HER2,cardiotoxicity,0.045864894181816544,0.10702958547060336,0.02096198959914018,0.03621333545427276,0.08964049328408658,0.18121014174252925,0.9198465933779252
NCT00000194,Ipilimumab,CTLA-4,immune_related,0.12071005297070078,0.030386705771590916,0.027444991601856324,0.3900658989094139,0.16219925176882433,0.12250242786603756,0.857781778518596
NCT00000195,Blinatumomab,CD19/CD3,neurotoxicity,0.13707320599558295,0.05798835132713181,0.036907544151432194,0.023098255833742844,0.09952558246559794,0.14841129547256487,0.9161659607923246
NCT00000196,Adalimumab,TNF-alpha,infection,0.06218327333612779,0.05919232736760443,0.021913472486657933,0.06033095482005407,0.17603049519645197,0.1493371545732129,0.9118353870366485
NCT00000197,Bevacizumab,VEGF,vascular,0.042496176679372326,0.04328394638681836,0.07194685944903141,0.13570734170012003,0.07318967597934156,0.2524201967379336,0.8968259671778971
NCT00000198,Pembrolizumab,PD-1,immune_related,0.19637261414934087,0.016677232453688823,0.03354045701484788,0.35944831432870017,0.14796229242296446,0.08749535875457015,0.8597506218126479
NCT00000199,Pembrolizumab,PD-1,immune_related,0.07119958483039782,0.053154192929453614,0.05788117261135915,0.3169097241155431,0.1633278411039436,0.08486446372300344,0.8754438367810499
NCT00000200,Ipilimumab,CTLA-4,immune_related,0.1651112718434085,0.02764166942857281,0.04491639658243127,0.2013605441920238,0.08012239491419451,0.09821644725911052,0.8971052126300431
NCT00000201,Bevacizumab,VEGF,vascular,0.08914373043047048,0.04658808550557876,0.010612894665419594,0.14427152095482015,0.14080606885243593,0.24867394769327134,0.886650625316334
NCT00000202,Trastuzumab,HER2,cardiotoxicity,0.04819121148427638,0.19390485277654668,0.036080344985645815,0.045747036612851635,0.15633022578395495,0.15288622312964087,0.894476684204514
NCT00000203,Ipilimumab,CTLA-4,immune_related,0.17879793652111853,0.0794928751238797,0.026514744711655613,0.13151316290878212,0.1898511127792365,0.10635290756145396,0.8812462100656456
NCT00000204,Daratumumab,CD38,infusion_reactions,0.07811980352719282,0.016483724570256174,0.06237041338163196,0.06661969736022325,0.18752025197408967,0.5887665096332567,0.8333532665922249
NCT00000205,Adalimumab,TNF-alpha,infection,0.015468672692555162,0.048176400248457554,0.028779429561481912,0.1645676534952673,0.09795094029887365,0.23724835826869128,0.9013014242391122
NCT00000206,Pembrolizumab,PD-1,immune_related,0.13206275748254437,0.037958396081984765,0.04374008185719447,0.23064382075312206,0.10884473133078663,0.18829553262914667,0.8764091133108702
NCT00000207,Blinatumomab,CD19/CD3,neurotoxicity,0.10473564235832591,0.05702320925157333,0.0776610535968092,0.0868937263003429,0.12403531451934059,0.08537939915470179,0.9107119424698177
NCT00000208,Cetuximab,EGFR,skin_toxicity,0.08325517368244634,0.028401565717557337,0.07753998029768086,0.14860546400268074,0.10310076547207567,0.11280984072407714,0.907714535017247
NCT00000209,Blinatumomab,CD19/CD3,neurotoxicity,0.07480322323356864,0.09425822488751967,0.11197875531125116,0.1496234463104127,0.15638338795643048,0.08383481160595678,0.8881863584491434
NCT00000210,Cetuximab,EGFR,skin_toxicity,0.08341298356735258,0.08464672142750276,0.011080330498111858,0.09493452975348116,0.04405585225879363,0.06676200329011363,0.935851263200774
NCT00000211,Trastuzumab,HER2,cardiotoxicity,0.07838832937473185,0.19355215289026045,0.017506977081080566,0.07552361374726763,0.13065972416690766,0.11620702608632233,0.8980270294422382
NCT00000212,Adalimumab,TNF-alpha,infection,0.018555090483249624,0.0521824692450531,0.027209832350499334,0.08308150272475061,0.10946497426431558,0.10650737759649277,0.9338331255559398
NCT00000213,Blinatumomab,CD19/CD3,neurotoxicity,0.09803504542990121,0.09350915489597365,0.04020386763856287,0.1677357974951858,0.15889490535994247,0.1961170962626545,0.87425068881963
NCT00000214,Ipilimumab,CTLA-4,immune_related,0.09586254809119715,0.05371506552166655,0.05226146872896428,0.17642481526981063,0.15820339864730737,0.14890513554504675,0.8857712613660012
NCT00000215,Blinatumomab,CD19/CD3,neurotoxicity,0.020846657626103434,0.02371796227446098,0.09037238861477793,0.07039739602877607,0.0620700187249896,0.07558053122219459,0.9428358409181162
NCT00000216,Tocilizumab,IL-6,infection,0.1215638273442126,0.06285853555824393,0.09426597768160787,0.07942883419705947,0.14351658922839192,0.1980424936949745,0.883387290382585
NCT00000217,Tocilizumab,IL-6,infection,0.0488132506261188,0.0826569623973511,0.10584702423026851,0.14032944443569598,0.09574509407199229,0.09202484712502133,0.905763896185592
NCT00000218,Cetuximab,EGFR,skin_toxicity,0.1196710882518913,0.0990178503057354,0.020047209577636282,0.16460368909453052,0.04343866484562556,0.09120459682394562,0.9103361501834393
NCT00000219,Tocilizumab,IL-6,infection,0.13244597256209373,0.039100408829755094,0.10855486763032247,0.029394053702469804,0.10187284208206461,0.15992225525044973,0.9047849333238074
NCT00000220,Cetuximab,EGFR,skin_toxicity,0.10307791207757941,0.0394380427690614,0.06504126156569136,0.04111336934074104,0.10962322162776787,0.1443273879101865,0.9162298007848287
NCT00000221,Cetuximab,EGFR,skin_toxicity,0.06397418021317006,0.05270302014015055,0.044293801577772476,0.11395742682408501,0.10490968117499311,0.27082140223194096,0.8915567479729813
NCT00000222,Ipilimumab,CTLA-4,immune_related,0.1763286831385263,0.07687520862838731,0.09563919462786309,0.350081480170198,0.19226953557563425,0.1759814155518002,0.8221374137179318
NCT00000223,Bevacizumab,VEGF,vascular,0.08846802116804237,0.054108415414087306,0.09678615612953374,0.14336616532238694,0.10926481354208246,0.15885334322618716,0.8915255141996133
NCT00000224,Adalimumab,TNF-alpha,infection,0.05874526847095591,0.012276599913481314,0.05022558930584009,0.10389365850935922,0.12720625560997909,0.23212287579491347,0.9025882920659118
NCT00000225,Rituximab,CD20,infusion_reactions,0.029240196462926846,0.03239176090845312,0.07985300790103102,0.1439407148890078,0.17649148311347643,0.27160224000570904,0.8777467661198993
NCT00000226,Adalimumab,TNF-alpha,infection,0.11466798930884432,0.010960517955014463,0.05862886242351719,0.11468046706229412,0.020898326142058856,0.12759767459417048,0.9254276937523501
NCT00000227,Trastuzumab,HER2,cardiotoxicity,0.01658759388158361,0.21066022794501582,0.02015041306698124,0.0937251162606445,0.14101616211946438,0.056705638240602776,0.910192474747618
NCT00000228,Blinatumomab,CD19/CD3,neurotoxicity,0.048493198527651785,0.053086138187695,0.014830912646138384,0.14518983354246323,0.0604860726287053,0.20631760294963974,0.9119327069196177
NCT00000229,Blinatumomab,CD19/CD3,neurotoxicity,0.14595969721753393,0.0840993137861668,0.10495038538413677,0.1869634710605865,0.17955705238288194,0.208060020682366,0.8484016765810547
NCT00000230,Cetuximab,EGFR,skin_toxicity,0.07864206794148634,0.052610357459591625,0.10624305144869038,0.15510554297421664,0.14918890965448292,0.05954839842307168,0.8997769453497434
NCT00000231,Blinatumomab,CD19/CD3,neurotoxicity,0.01403717581785371,0.09048386219291345,0.02685109255925084,0.1525153104353203,0.15934611541145216,0.0829120514594477,0.9123090653539603
NCT00000232,Ipilimumab,CTLA-4,immune_related,0.11293588746420789,0.06920621945232058,0.02448383953772664,0.2912434467164968,0.062465094498152365,0.06462131909045238,0.8958406988734405
NCT00000233,Adalimumab,TNF-alpha,infection,0.08617168798183605,0.09850630854615441,0.03136006163106542,0.130520682280821,0.022667912641364314,0.25931838205455043,0.8952424941440347
NCT00000234,Rituximab,CD20,infusion_reactions,0.08634070233233261,0.022659211426298755,0.05965162673477045,0.14057247488667834,0.21736949789842297,0.577720389861633,0.8159476828099773
NCT00000235,Pembrolizumab,PD-1,immune_related,0.1274510674336976,0.0758381613084277,0.052253846774327,0.35131500214574296,0.1839282349668196,0.05974323510334632,0.8582450753779398
NCT00000236,Tocilizumab,IL-6,infection,0.12550665606991224,0.05513731243667197,0.09018527730800174,0.03511436604757115,0.09094381933749728,0.1188813638100941,0.9140385341650419
NCT00000237,Blinatumomab,CD19/CD3,neurotoxicity,0.0378156761558379,0.05549192478383062,0.029026503487549475,0.15442911708043758,0.15405755155216447,0.050806095658176606,0.9197288552136672
NCT00000238,Ipilimumab,CTLA-4,immune_related,0.0910644708878093,0.03454793444454685,0.04731619922295348,0.2704519797178484,0.18925843698694594,0.1349283932860265,0.872072097575645
NCT00000239,Rituximab,CD20,infusion_reactions,0.051670483484376785,0.01465046760976645,0.016339320337586605,0.12295503771783235,0.1371317778788526,0.43645941205807004,0.8701322501522525
NCT00000240,Cetuximab,EGFR,skin_toxicity,0.14520718338202707,0.07900503117770125,0.09676103466114593,0.05915465336166478,0.07992472941917074,0.07031873329952058,0.911604772449795
NCT00000241,Pembrolizumab,PD-1,immune_related,0.15864151486371159,0.027271248262709095,0.08698466579967176,0.29269521745143257,0.23029583970395612,0.078662908912534,0.8542414341676642
NCT00000242,Trastuzumab,HER2,cardiotoxicity,0.0629082780455629,0.13982044453282744,0.012133412176165117,0.07647311704580578,0.07670060539129755,0.07808521474158757,0.9256464880111256
NCT00000243,Cetuximab,EGFR,skin_toxicity,0.054175737186950346,0.030336434209158825,0.030706982016622544,0.1790423442114922,0.0483379339924791,0.1237330862495193,0.922277913688963
NCT00000244,Adalimumab,TNF-alpha,infection,0.10765814245897355,0.0338090629005215,0.06388742267390222,0.12416530955918413,0.07581747147127453,0.2104564777073315,0.8973676855381354
NCT00000245,Tocilizumab,IL-6,infection,0.07295424026347702,0.0667923766511201,0.10149034856820262,0.026611596874443595,0.15355587075379248,0.14642017289195997,0.9053625656661674
NCT00000246,Daratumumab,CD38,infusion_reactions,0.05841539055991186,0.018426511881874687,0.05915312268115385,0.084692153070873,0.2621816645294692,0.5185085603257686,0.8331037661584915
NCT00000247,Bevacizumab,VEGF,vascular,0.039042574077139514,0.07296884437772737,0.06541417770592296,0.16937438289645104,0.14708720477694284,0.07268937511979127,0.9055705735076709
NCT00000248,Cetuximab,EGFR,skin_toxicity,0.1182772593908092,0.03323924645515488,0.061445701708592856,0.025660649135302662,0.038447709699904686,0.21458304530217065,0.9180577313846775
NCT00000249,Blinatumomab,CD19/CD3,neurotoxicity,0.03609957148529123,0.02258337536493106,0.07455028374142203,0.08701089457779003,0.08046562511718845,0.19709769543497802,0.9170320923797332
NCT00000250,Rituximab,CD20,infusion_reactions,0.013046480707924687,0.03805153134602695,0.05406304556967237,0.1369329101599932,0.1015796604137875,0.36856310509293055,0.8812938777849442
NCT00000251,Adalimumab,TNF-alpha,infection,0.05685974692653161,0.0683093182092025,0.021022845660017928,0.18436678815216434,0.06900410075514989,0.16671030809502696,0.9056211487003178
NCT00000252,Pembrolizumab,PD-1,immune_related,0.07792410897319597,0.011522497838218576,0.08473770655191679,0.2369337028121384,0.1651930402137316,0.11524527154597067,0.8847406120108047
NCT00000253,Ipilimumab,CTLA-4,immune_related,0.10990002208229759,0.06838674878367193,0.04020598156653192,0.21196443349333538,0.11757565212630866,0.15178337626288063,0.883363964280829
NCT00000254,Trastuzumab,HER2,cardiotoxicity,0.03101213084764054,0.39122970162851267,0.045097308526725485,0.08105383928701546,0.18512982866937638,0.151392151576065,0.8525141732441107
NCT00000255,Ipilimumab,CTLA-4,immune_related,0.11314789774927597,0.06418507135551622,0.09631855522244454,0.22022503821494294,0.05571103418473298,0.1268306525420972,0.8872636251218317
NCT00000256,Adalimumab,TNF-alpha,infection,0.1391295036828636,0.08979357215550991,0.11617591721370417,0.18971233974647062,0.05175394290863737,0.29310693809387883,0.8533879643664892
NCT00000257,Blinatumomab,CD19/CD3,neurotoxicity,0.11525901287449065,0.02169017441352142,0.0466461825873154,0.19278439379993095,0.17525202046680288,0.1273183848575939,0.8868416385000575
NCT00000258,Trastuzumab,HER2,cardiotoxicity,0.06360761783944269,0.3404468871938492,0.028348540781734544,0.03322736648356183,0.05012648141973682,0.07949820190728683,0.9007908173957313
NCT00000259,Cetuximab,EGFR,skin_toxicity,0.13361366364426597,0.037115410027484655,0.0188412797473766,0.06251304488179978,0.05253151707237824,0.0725417236315727,0.9371405601658537
NCT00000260,Bevacizumab,VEGF,vascular,0.04426255316718898,0.07162422187612459,0.10302352357891899,0.08736640588112221,0.09637505431095339,0.1361779658122239,0.910195045895578
NCT00000261,Bevacizumab,VEGF,vascular,0.07591209722292473,0.07181077946323347,0.08686577233205814,0.1843099482731154,0.12694989606892057,0.2578367480328008,0.8660524597678245
NCT00000262,Ipilimumab,CTLA-4,immune_related,0.15593361509152726,0.06341393213113011,0.027665989033921905,0.1385507180952058,0.20260885944256546,0.0700289402900825,0.8902996576525946
NCT00000263,Cetuximab,EGFR,skin_toxicity,0.11825646151450019,0.09082191612934704,0.10017701837586206,0.15146697936268957,0.08793479036919935,0.1484625900799691,0.8838133740280721
NCT00000264,Ipilimumab,CTLA-4,immune_related,0.060748519391045544,0.044181653014506155,0.0792343294443045,0.27592868661931813,0.09433880878327508,0.1412783501798213,0.8840482754279548
NCT00000265,Ipilimumab,CTLA-4,immune_related,0.16517658893222836,0.03583927963196956,0.04718807607975955,0.34697144255397816,0.17211330473299352,0.16275266900455293,0.844993106510753
NCT00000266,Ipilimumab,CTLA-4,immune_related,0.18718790010802783,0.055190408796855384,0.03104639202353339,0.1563911647593556,0.09224646881511496,0.1153100942367878,0.8937712618767208
NCT00000267,Rituximab,CD20,infusion_reactions,0.04056279901091745,0.03616179739829172,0.039799792398157195,0.07849641241959636,0.17736310314427753,0.5285100057144524,0.8498510149857179
NCT00000268,Ipilimumab,CTLA-4,immune_related,0.05522399909163209,0.07709589218237396,0.05373895119399903,0.14906286313731104,0.18646795528732024,0.1751348742542012,0.8838792441421938
NCT00000269,Adalimumab,TNF-alpha,infection,0.075089178330243,0.017437642448885873,0.0854672181650532,0.03825291736465951,0.15799463677939599,0.250887564210064,0.8958118071169497
NCT00000270,Bevacizumab,VEGF,vascular,0.011711428482262252,0.03871232004155633,0.07321504306619425,0.08911825137983082,0.09275073052834112,0.17153484607826402,0.9204928967372585
NCT00000271,Daratumumab,CD38,infusion_reactions,0.09639289468763429,0.026068135625856234,0.06399517620962701,0.08029545130206733,0.1517298098535314,0.45364687179314617,0.8546452767546896
NCT00000272,Blinatumomab,CD19/CD3,neurotoxicity,0.09450904662160209,0.0822176555673702,0.05952969353814999,0.08710855678156491,0.09576756562235769,0.13376587712051047,0.9078502674580741
NCT00000273,Blinatumomab,CD19/CD3,neurotoxicity,0.08490338322555893,0.04283756084777782,0.09640441961342357,0.19653221142539173,0.10507386059714649,0.14586795581563244,0.8880634347458448
NCT00000274,Cetuximab,EGFR,skin_toxicity,0.10446064733863825,0.0235348498122849,0.04708272586988012,0.18815187370301523,0.11442448289136475,0.09940326235237769,0.9038236930054065
NCT00000275,Rituximab,CD20,infusion_reactions,0.08315515984078355,0.039105150661529656,0.041849255341605565,0.05485435982403395,0.15634279108024304,0.24862057825296136,0.8960121174998071
NCT00000276,Blinatumomab,CD19/CD3,neurotoxicity,0.07854699763979835,0.04303937088330549,0.10780825284068364,0.14354977493340787,0.06037228873455826,0.13436543620190822,0.905386313127723
NCT00000277,Tocilizumab,IL-6,infection,0.051460223550772094,0.08372524084238507,0.06970233477201988,0.0521710724590953,0.07710165788776902,0.0543797482676248,0.9352432870367223
NCT00000278,Blinatumomab,CD19/CD3,neurotoxicity,0.05544855700191608,0.06723844299618421,0.07553567962560923,0.08430400678323789,0.025857976116262105,0.23467007651219995,0.9094908768274318
NCT00000279,Ipilimumab,CTLA-4,immune_related,0.08729400766108221,0.015883280168838533,0.027565805987152227,0.3180362212910749,0.17658400460101709,0.11466508197715508,0.87666193305228
NCT00000280,Blinatumomab,CD19/CD3,neurotoxicity,0.048457472684637286,0.09746674978153988,0.08578911571127566,0.06393812675311807,0.1520914255423313,0.25872947561045423,0.8822546056527739
NCT00000281,Pembrolizumab,PD-1,immune_related,0.15990316661501563,0.046649112327656,0.05667356553115903,0.12296084313077138,0.12455906575662996,0.0720125670835601,0.9028736132592013
NCT00000282,Adalimumab,TNF-alpha,infection,0.14675806657473317,0.06740330348255398,0.10702405766489727,0.08874433914030946,0.17684263792681582,0.06969121645721184,0.8905893964589131
NCT00000283,Bevacizumab,VEGF,vascular,0.13984167716759255,0.07743402993067158,0.05647828999222334,0.02402902553310589,0.17205742090555073,0.11421450101136034,0.9026575092432493
NCT00000284,Tocilizumab,IL-6,infection,0.1014053607283226,0.08946328257870298,0.10205386489896573,0.09801835100150712,0.038628068916374186,0.09791090930047468,0.9120866937626088
NCT00000285,Cetuximab,EGFR,skin_toxicity,0.04653660475677682,0.03728812773080418,0.06654435298820836,0.17376385690920224,0.05900038444311276,0.24973852494513843,0.8945213580377929
NCT00000286,Ipilimumab,CTLA-4,immune_related,0.10613545802235903,0.043104288019721576,0.08085752364127533,0.23108369024422784,0.19937395854124917,0.16674634611500072,0.8621164559026944
NCT00000287,Tocilizumab,IL-6,infection,0.048759533541044814,0.07042956765083072,0.07650848249982126,0.18375435376634355,0.12851331983198225,0.11816985086547406,0.8956441486407506
NCT00000288,Bevacizumab,VEGF,vascular,0.06700559086351905,0.01168470539439135,0.055575732382337796,0.04335804976119367,0.06272852475934174,0.19976986272308644,0.9266462556860217
NCT00000289,Daratumumab,CD38,infusion_reactions,0.09783078601313457,0.022726375787600187,0.0254926579873095,0.05180729233399667,0.16492176684894816,0.2254889834266492,0.9019553562670602
NCT00000290,Adalimumab,TNF-alpha,infection,0.05029638366358693,0.07408302437393705,0.10096724741660695,0.12582454961342857,0.12156362604526372,0.13218800377372264,0.8991795275189091
NCT00000291,Trastuzumab,HER2,cardiotoxicity,0.03723276587793382,0.37896180873585594,0.010502688986942385,0.04724767823198009,0.10195494721378613,0.1388766127106229,0.8808705830404798
NCT00000292,Rituximab,CD20,infusion_reactions,0.051575279659718566,0.03970284625857313,0.024744617620533895,0.11977253643424317,0.23459719030568188,0.3022770387021846,0.8712217485031775
NCT00000293,Ipilimumab,CTLA-4,immune_related,0.05483997649777512,0.06966041743749328,0.09741788868821175,0.28941521902353734,0.1622651472463417,0.10179487885880321,0.8707677453746396
NCT00000294,Ipilimumab,CTLA-4,immune_related,0.08113268026859785,0.07894080234372185,0.049535316410084206,0.18754691276890978,0.11306761719509838,0.15117520555933578,0.889766910909042
NCT00000295,Tocilizumab,IL-6,infection,0.01413903953005425,0.06623764278474689,0.028340773572543,0.08329274804652213,0.08904492666172145,0.2989564600678909,0.9033314015560869
NCT00000296,Adalimumab,TNF-alpha,infection,0.013277168163615287,0.09760213617645123,0.07120834359411687,0.10833623780416282,0.05755497023497144,0.2802940702766044,0.895287845625013
NCT00000297,Pembrolizumab,PD-1,immune_related,0.06975460839841012,0.05249852200163407,0.08797345526426674,0.12909394665602525,0.09366107614532881,0.19881963593210966,0.8946997926003709
NCT00000298,Pembrolizumab,PD-1,immune_related,0.1356117523715075,0.02250357069479324,0.03272940144948639,0.33325740393485737,0.19689214226439072,0.11016747640453692,0.861473042146738
NCT00000299,Ipilimumab,CTLA-4,immune_related,0.11127742791774642,0.06258966442378373,0.053454399645602044,0.27977456140267787,0.11388069953098844,0.10447620223865918,0.8790911741400904
NCT00000300,Adalimumab,TNF-alpha,infection,0.024789428807741692,0.08962820799511634,0.11562633402379963,0.15711556370942475,0.07084401548183519,0.18390676217620894,0.8930149479676456
NCT00000301,Daratumumab,CD38,infusion_reactions,0.04529560297920502,0.04436226350187241,0.04463832499815503,0.09639139420262233,0.2652276872464274,0.3797823702006572,0.8540503928118435
NCT00000302,Blinatumomab,CD19/CD3,neurotoxicity,0.1393474780192067,0.025986396491564007,0.041724859106295635,0.11587982706260633,0.07344877572409499,0.16600537161564566,0.9062678819967644
NCT00000303,Blinatumomab,CD19/CD3,neurotoxicity,0.03411789354435539,0.09165527968741266,0.05216887663168728,0.13755876343889523,0.17587958266528794,0.15257345100655212,0.8926743588376349
NCT00000304,Daratumumab,CD38,infusion_reactions,0.06727751875380941,0.03475503868585605,0.019700042923386576,0.11199202947568986,0.2997819767601875,0.4398272680359623,0.8377776875608514
NCT00000305,Rituximab,CD20,infusion_reactions,0.07589331952325831,0.047819560773025044,0.03275142172490712,0.07499407542233084,0.21386122945769892,0.3887654175888391,0.8609858292516568
NCT00000306,Trastuzumab,HER2,cardiotoxicity,0.016367650826493097,0.21108877365898976,0.039718614995879704,0.09068099843852512,0.14811740672887047,0.16041147189041294,0.8889358472434715
NCT00000307,Trastuzumab,HER2,cardiotoxicity,0.07044067906969942,0.35509270410211413,0.016455170946648386,0.049525145723259514,0.1811975295536019,0.08504219870592486,0.8737077619831253
NCT00000308,Pembrolizumab,PD-1,immune_related,0.19057113309889195,0.07449699792254694,0.045817936141878395,0.18789457469764237,0.22888913159204982,0.08105109063267958,0.8652131893190518
NCT00000309,Cetuximab,EGFR,skin_toxicity,0.07456514227604126,0.03205422737844585,0.07635738856197781,0.1981483990217675,0.14748056909665808,0.29320132185035613,0.8630321586357922
NCT00000310,Trastuzumab,HER2,cardiotoxicity,0.04501504573893956,0.1333471889876283,0.03416027183469398,0.04650073878293362,0.1880233722651884,0.08185331708917537,0.9118500108835734
NCT00000311,Cetuximab,EGFR,skin_toxicity,0.07470971257304009,0.09662266236756596,0.010757164525590415,0.025818062296243352,0.12829958010476433,0.266765678524538,0.899504523268043
NCT00000312,Tocilizumab,IL-6,infection,0.14937483702472812,0.08759520735352042,0.017740217492987962,0.09507612997564277,0.061604679683872496,0.22899414438259125,0.8932691306811095
NCT00000313,Trastuzumab,HER2,cardiotoxicity,0.018468738199067407,0.3329789585031053,0.03588357358849311,0.06273366493866694,0.05355801892115301,0.14616151277386225,0.891702588845942
NCT00000314,Adalimumab,TNF-alpha,infection,0.11164444512404557,0.03636667641289246,0.05382364102537819,0.16801683642362875,0.1430018425463515,0.1408433169115883,0.8910505402593525
NCT00000315,Trastuzumab,HER2,cardiotoxicity,0.06016372371403347,0.25346790990814905,0.03598519219161445,0.05428708302225084,0.06860852700131723,0.07919674790959118,0.9080484693755073
NCT00000316,Trastuzumab,HER2,cardiotoxicity,0.02837493697595469,0.3475685773338646,0.040143114266281886,0.028942698670622234,0.07534301992483194,0.1325786108621016,0.8911748403277239
NCT00000317,Pembrolizumab,PD-1,immune_related,0.1009751936144569,0.07390822132687871,0.08364424793874682,0.16302549525612825,0.0694251408130313,0.1463053357158408,0.8937860608891529
NCT00000318,Trastuzumab,HER2,cardiotoxicity,0.015184868887640098,0.36975859338585193,0.029663077221066494,0.039578275535691126,0.08899993301456002,0.10905841393648702,0.8912928063364506
NCT00000319,Rituximab,CD20,infusion_reactions,0.05002048589110009,0.04149495793890243,0.058969317064095465,0.1068231189811967,0.2188856259521017,0.5045290951133399,0.836546233176544
NCT00000320,Trastuzumab,HER2,cardiotoxicity,0.02036167820188813,0.1865291290564995,0.01884086158280688,0.04966808948727812,0.1044086352517491,0.10824365959564258,0.9186579911373559
NCT00000321,Bevacizumab,VEGF,vascular,0.142270867528149,0.02424722009217436,0.07972840378822049,0.10555127164985381,0.09037797650489653,0.12371990411438287,0.9056840593870539
NCT00000322,Trastuzumab,HER2,cardiotoxicity,0.06206132163378526,0.3085247549307788,0.01586104560120386,0.043386630331961884,0.10763400114026565,0.1773524660288066,0.8808632967221997
NCT00000323,Cetuximab,EGFR,skin_toxicity,0.01392065867132455,0.029049583915552,0.043325222405195006,0.125162259356469,0.06150738759536957,0.23028484193345822,0.9161250076871053
NCT00000324,Rituximab,CD20,infusion_reactions,0.07709115146339633,0.04984470084810792,0.03840912426552328,0.11184599913657009,0.13408202524841323,0.3376854170675621,0.8751735969950711
NCT00000325,Tocilizumab,IL-6,infection,0.031822759972504965,0.08673494253381026,0.04457258580302533,0.08738526499298344,0.1584653901172665,0.17131144599686654,0.9032846017639238
NCT00000326,Pembrolizumab,PD-1,immune_related,0.07536813155276581,0.04676658096718545,0.03403098850488569,0.36914008195669734,0.052846519155420074,0.1920422379651136,0.871634243316322
NCT00000327,Rituximab,CD20,infusion_reactions,0.04081302955921193,0.022372331382760187,0.025701699260668433,0.07783155486631485,0.2556028719674972,0.5157096985566361,0.8436614690678186
NCT00000328,Cetuximab,EGFR,skin_toxicity,0.1009995326963954,0.04208513174124898,0.06052538829024791,0.18428645100410718,0.16500832439923377,0.25999428396347274,0.8645168146508824
NCT00000329,Pembrolizumab,PD-1,immune_related,0.17686189020301757,0.06481612067772433,0.06192946666367928,0.16851139606843413,0.0905059968882208,0.1496366128692484,0.8812897527716126
NCT00000330,Ipilimumab,CTLA-4,immune_related,0.1097736835029744,0.016918801416769463,0.046361206476340594,0.12015931815983405,0.1606568961764219,0.1302130809202108,0.9026528355579081
NCT00000331,Pembrolizumab,PD-1,immune_related,0.1611886831422103,0.07108309295446658,0.09763497757787573,0.11679243992261482,0.1633404322310519,0.0871957919501054,0.8837940970369459
NCT00000332,Trastuzumab,HER2,cardiotoxicity,0.027925045086509656,0.32183073352877345,0.03758796153555317,0.07206457725615657,0.08676305774041257,0.18792749005165743,0.8776501891334896
NCT00000333,Blinatumomab,CD19/CD3,neurotoxicity,0.07384924713403204,0.013620951310872832,0.07700514792825255,0.11935561783571379,0.03461747138871008,0.09750354165832929,0.9306746704573482
NCT00000334,Bevacizumab,VEGF,vascular,0.12629693320725377,0.015730204221253735,0.10934469457403109,0.11406038608027216,0.02973841811148171,0.10689656221110484,0.9163221335991004
NCT00000335,Trastuzumab,HER2,cardiotoxicity,0.05099741737036135,0.27438113125551267,0.028570851712903446,0.06295469157793564,0.16721188804255738,0.11377166776361483,0.8836853920461858
NCT00000336,Daratumumab,CD38,infusion_reactions,0.06705151316951892,0.017857033156841708,0.01814844743112374,0.05833862086835191,0.1394792483745156,0.41694753345661123,0.8803629339238395
NCT00000337,Cetuximab,EGFR,skin_toxicity,0.040099152056583216,0.053850760139498764,0.07262621962321007,0.12470843819794072,0.15778225648997884,0.07788097545501114,0.9121753663396295
NCT00000338,Adalimumab,TNF-alpha,infection,0.13411244766391703,0.07996562777337776,0.03142786409544296,0.16503785561239614,0.11830612511103517,0.16406360937699244,0.8845144117278064
NCT00000339,Adalimumab,TNF-alpha,infection,0.010069317186211705,0.07791042250875531,0.07614895611838811,0.10866892511846928,0.04824510017471241,0.17682324551656775,0.9170223388961493
NCT00000340,Rituximab,CD20,infusion_reactions,0.0562780211533458,0.04805742789664258,0.030974608723029443,0.13672609666898103,0.14980440041593057,0.31011533939195435,0.8780073509583527
NCT00000341,Pembrolizumab,PD-1,immune_related,0.13418964762582886,0.03161628122489542,0.05520350403277281,0.3931686991973494,0.2391394036742751,0.12313706614805454,0.8372575663494707
NCT00000342,Daratumumab,CD38,infusion_reactions,0.03872867934706097,0.04897417560504315,0.04293544303406145,0.06631308732837078,0.11311189496582419,0.3728059669523721,0.8861884587945446
NCT00000343,Rituximab,CD20,infusion_reactions,0.03741768813514052,0.047011813480266895,0.04102388332761988,0.11378829753917376,0.20771801892304073,0.2730622684764728,0.8799963383530476
NCT00000344,Trastuzumab,HER2,cardiotoxicity,0.06451542554505034,0.32885579444125923,0.018528657945156193,0.060142373624672785,0.0980023791265717,0.1560799039481217,0.8789792442281947
NCT00000345,Ipilimumab,CTLA-4,immune_related,0.06543756762677391,0.03100429933464978,0.06876213503497358,0.27130252794598175,0.08091952998007153,0.07345815881181962,0.9015192968776217
NCT00000346,Trastuzumab,HER2,cardiotoxicity,0.06364781676036715,0.33574333825359637,0.044094291376454584,0.06880985835945054,0.07356989867130062,0.24134139644573077,0.8621322333555167
NCT00000347,Pembrolizumab,PD-1,immune_related,0.19717316121657402,0.05574434408296701,0.0830998905997927,0.3339264736916161,0.10387663726318418,0.1899265318321311,0.8393754935522891
NCT00000348,Cetuximab,EGFR,skin_toxicity,0.07607743435208644,0.08706137832328315,0.0433979933022486,0.04609757494272164,0.0733955463489409,0.13848339287420974,0.9225811133094183
NCT00000349,Ipilimumab,CTLA-4,immune_related,0.161782090345785,0.04147955128223585,0.05402383301453971,0.2180626618028326,0.13342472762714702,0.16433341161160242,0.8711489540526429
NCT00000350,Cetuximab,EGFR,skin_toxicity,0.06657135492371796,0.09718119574182406,0.04889731542048751,0.1649667361765165,0.17599772150145734,0.2417621498447048,0.8674372543985487
NCT00000351,Tocilizumab,IL-6,infection,0.012727147300501382,0.07339050187318905,0.032946994623735605,0.14900108565440237,0.06716750244206397,0.14336879667579938,0.9202329952383848
NCT00000352,Daratumumab,CD38,infusion_reactions,0.03896612158771493,0.04163679879379461,0.032797959290927436,0.10599722619281482,0.13989042907576948,0.2859919417427654,0.8924532538860356
NCT00000353,Tocilizumab,IL-6,infection,0.08041207910786896,0.0870763098050406,0.02175180336972296,0.0637648067539575,0.07207728591304915,0.16992067460249022,0.9174995067413118
NCT00000354,Pembrolizumab,PD-1,immune_related,0.1581895968984145,0.042891023134016805,0.09769065376919991,0.11379998500919625,0.18188364712903354,0.1531701448854786,0.8753958248624434
NCT00000355,Ipilimumab,CTLA-4,immune_related,0.18633310203234332,0.04409289440132103,0.042411409012633086,0.2820114528822475,0.1250037924339128,0.06521598740232873,0.8758218936392023
NCT00000356,Pembrolizumab,PD-1,immune_related,0.14594429993185246,0.029323235434686394,0.04955590631850026,0.37708182770960486,0.07220615814900527,0.07014271007573203,0.8759576437301031
NCT00000357,Ipilimumab,CTLA-4,immune_related,0.16247393124623832,0.032718186217565184,0.08201943262365402,0.2241332139618189,0.08035451751045974,0.07256293623500502,0.8909562970342098
NCT00000358,Blinatumomab,CD19/CD3,neurotoxicity,0.05183978811183822,0.02799948767248745,0.01968056744492599,0.06414080037930295,0.11163730686495918,0.24069679018238704,0.9140008765573499
NCT00000359,Adalimumab,TNF-alpha,infection,0.04650067849408402,0.057792473163887116,0.04205613230059083,0.023933325598270893,0.14353611441839442,0.06700097670913734,0.9365300498859392
NCT00000360,Tocilizumab,IL-6,infection,0.1200260993681489,0.07402624209609063,0.04453573610851179,0.1736179991440574,0.1648165592821872,0.16146009293808267,0.8769195451771535
NCT00000361,Blinatumomab,CD19/CD3,neurotoxicity,0.13384193055386687,0.026572602606669382,0.061515903883017975,0.10294466424879942,0.07328193569062373,0.219417200556842,0.8970709604100301
NCT00000362,Adalimumab,TNF-alpha,infection,0.10856844347911784,0.032982199894827,0.0922415308102588,0.024164895454411122,0.03907046990661648,0.15269473758960317,0.9250462871441942
NCT00000363,Ipilimumab,CTLA-4,immune_related,0.10944619715891571,0.04404502716561251,0.02384248663882878,0.2585192145264589,0.2325964405978368,0.12683925037101773,0.8674518972568883
NCT00000364,Blinatumomab,CD19/CD3,neurotoxicity,0.012268177711963963,0.04934862248308139,0.013529241946166063,0.11075808061029434,0.14772451916583776,0.24753437589632232,0.9031394970310557
NCT00000365,Daratumumab,CD38,infusion_reactions,0.054280852343426486,0.03299261877946632,0.05440616909189271,0.1234433807995562,0.21306136115214752,0.5896910147615988,0.822020767178652
NCT00000366,Blinatumomab,CD19/CD3,neurotoxicity,0.11928234946524267,0.05785861934900398,0.09784500745300231,0.1723338815068265,0.03403684088459638,0.280624220275221,0.8730031801776845
NCT00000367,Trastuzumab,HER2,cardiotoxicity,0.05270220380658046,0.3978849176858831,0.0400762939670931,0.08136922281024048,0.11464200930791621,0.10537298242109293,0.8679920616668656
NCT00000368,Blinatumomab,CD19/CD3,neurotoxicity,0.07318040225289618,0.08924865282693112,0.09128302482323783,0.13707986563054694,0.03168412587842204,0.21195996585343735,0.8942606604557548
NCT00000369,Tocilizumab,IL-6,infection,0.05757336067830465,0.05749425709471228,0.08618447833761905,0.16763753481753665,0.08918354736494659,0.055370882156241794,0.9144259899251065
NCT00000370,Cetuximab,EGFR,skin_toxicity,0.0904632978225792,0.010571856097370958,0.10110449070404637,0.023396897029406002,0.056036789801578876,0.15678741177636185,0.9269398761281095
NCT00000371,Tocilizumab,IL-6,infection,0.0462394130213592,0.03006009878660651,0.08419921438735478,0.07879147019852377,0.0932405312700423,0.21635046750368836,0.9085198008054042
NCT00000372,Daratumumab,CD38,infusion_reactions,0.07929350453568419,0.03297753659646408,0.03482517177259212,0.13803117403008375,0.2734486245764137,0.2610419129992943,0.863397012581578
NCT00000373,Ipilimumab,CTLA-4,immune_related,0.16594880016328822,0.02443009198899356,0.0345269376640895,0.1078673471512393,0.17038429371192265,0.1767047476464353,0.8866896302790053
NCT00000374,Ipilimumab,CTLA-4,immune_related,0.16691948264165618,0.04780533756611029,0.09637284759835416,0.19823831439887596,0.1130672498471521,0.08451557829026174,0.8821801982762649
NCT00000375,Adalimumab,TNF-alpha,infection,0.03923301553903668,0.037263655623018754,0.05667120023824571,0.06879402922046327,0.16980836262688428,0.10430895233963679,0.9206534640687858
NCT00000376,Adalimumab,TNF-alpha,infection,0.05974826711283252,0.022358094893301893,0.10887675951333738,0.0991353692275272,0.15346515887738907,0.14377848547962285,0.9021063108159981
NCT00000377,Daratumumab,CD38,infusion_reactions,0.04995572163222693,0.03975769515460375,0.061793893535441936,0.0880416565010058,0.1893624774195952,0.35967128038000384,0.8685695458961871
NCT00000378,Daratumumab,CD38,infusion_reactions,0.028506904090855538,0.02522019552892959,0.06701495914701709,0.0592851817378728,0.13501935676739113,0.5653132843324646,0.8532733530659116
NCT00000379,Adalimumab,TNF-alpha,infection,0.11143256762854355,0.020953337733890628,0.09322669925585521,0.041664498517850326,0.09825734822826623,0.20121210246978394,0.905542241027635
NCT00000380,Tocilizumab,IL-6,infection,0.11495556264631492,0.0385191622924917,0.031007925816893718,0.19732737866299135,0.14796659410823604,0.1399646197966839,0.8883764594460647
NCT00000381,Pembrolizumab,PD-1,immune_related,0.08829268050424971,0.017839465112557844,0.056556299934473905,0.10217667828506782,0.21068233463170222,0.11004625219281997,0.9024010482231881
NCT00000382,Trastuzumab,HER2,cardiotoxicity,0.0700245151445614,0.2064043298968504,0.04782927134930543,0.08692277077752686,0.11512233273603834,0.21956163145900048,0.8756891914394529
NCT00000383,Ipilimumab,CTLA-4,immune_related,0.09510416563156115,0.07997945948753488,0.02675611773159065,0.293074586563191,0.12793724220386418,0.12070421876294542,0.8760740349365521
NCT00000384,Pembrolizumab,PD-1,immune_related,0.1926963716345666,0.029230129056230465,0.07178876930316162,0.19698127965339163,0.07814716375979008,0.08734971826228319,0.8906344280550961
NCT00000385,Blinatumomab,CD19/CD3,neurotoxicity,0.08904109478964173,0.021515347262292962,0.027133414636732932,0.14511263791148576,0.14196605448602534,0.06529536507316767,0.9183226809734423
NCT00000386,Bevacizumab,VEGF,vascular,0.12233323819470093,0.08797105548222683,0.0827047409284063,0.08690672703951527,0.0863802192488321,0.08937067355818888,0.9073888909246883
NCT00000387,Bevacizumab,VEGF,vascular,0.03413879844881032,0.09426624280716457,0.11618302074560415,0.15355400074791287,0.14965114792426562,0.09540367306222768,0.8928005193773358
NCT00000388,Bevacizumab,VEGF,vascular,0.13307083762804886,0.019845241835639703,0.027861108580960435,0.10955997047375024,0.068970370773857,0.20632812189531347,0.9057273914687384
NCT00000389,Blinatumomab,CD19/CD3,neurotoxicity,0.13725731937437874,0.033866321041973096,0.0453180008615002,0.16098840180523252,0.07305312756120787,0.27220511263329966,0.879551952787068
NCT00000390,Pembrolizumab,PD-1,immune_related,0.05513341583492327,0.07104197368103159,0.09308615470388788,0.11394983501614986,0.12540735417977317,0.13977612151487476,0.9002675241782265
NCT00000391,Adalimumab,TNF-alpha,infection,0.08352864402356469,0.024235532052892236,0.011643230753789128,0.18149396508996146,0.03473982384190901,0.2970478770627188,0.8945518211958607
NCT00000392,Tocilizumab,IL-6,infection,0.025737482574747908,0.052812043292813,0.11817056660099665,0.17410527677585044,0.10587635211994151,0.0836013489531645,0.906616154947081
NCT00000393,Adalimumab,TNF-alpha,infection,0.09445795337348814,0.06731697134721984,0.044257397073408825,0.10450765655874325,0.16446127206905078,0.0820496527904206,0.9071581827979448
NCT00000394,Adalimumab,TNF-alpha,infection,0.10189239811597803,0.042902445391725615,0.0774970529491269,0.14893675265723236,0.0964463752422353,0.23717972902784,0.8825242077693103
NCT00000395,Cetuximab,EGFR,skin_toxicity,0.12927558600882838,0.027665838683582605,0.034124224235271984,0.04336537022129108,0.170766260793919,0.10638796027602614,0.9147357932968468
NCT00000396,Blinatumomab,CD19/CD3,neurotoxicity,0.021506457805975772,0.018531027097658262,0.054422238551474926,0.17964522623049184,0.036836513578628056,0.10655585089823362,0.9304171143062563
NCT00000397,Rituximab,CD20,infusion_reactions,0.026616408047845395,0.03637477436694746,0.03300380311706835,0.1473956744835892,0.23367127268133261,0.4079667702821027,0.8524952161701858
NCT00000398,Bevacizumab,VEGF,vascular,0.09080339519880716,0.08952245558802284,0.09358829795530836,0.04370727746955992,0.08752335235449157,0.2153004570775125,0.8965924607260496
NCT00000399,Bevacizumab,VEGF,vascular,0.09111159833593252,0.0941161969048333,0.013764784427530713,0.18308261546461918,0.08160480216965703,0.06200460790506536,0.9123858991320604
NCT00000400,Tocilizumab,IL-6,infection,0.037705461361514675,0.026395522291130992,0.02572499126053878,0.02614052705741103,0.14716355471352258,0.09047130122177972,0.941066440349017
NCT00000401,Adalimumab,TNF-alpha,infection,0.055154532951412726,0.061487805942221536,0.06322293463606274,0.08190231855060671,0.12059406741801004,0.25424737217050003,0.8938984947218643
NCT00000402,Blinatumomab,CD19/CD3,neurotoxicity,0.09080820736879078,0.050689370254746756,0.033631981014097444,0.13183626090962317,0.10734070830328822,0.07945478213012298,0.9177064483365551
NCT00000403,Rituximab,CD20,infusion_reactions,0.035137467525835665,0.040740442131307994,0.07467199417661521,0.0837254591261489,0.27850536880838783,0.3021137694745749,0.8641842497928549
NCT00000404,Daratumumab,CD38,infusion_reactions,0.08262896491942852,0.02949420594334834,0.048423055052326025,0.11632480703033761,0.23360253700049874,0.33695000935575165,0.8587627367830515
NCT00000405,Bevacizumab,VEGF,vascular,0.08267020908594777,0.015680599364458647,0.05019644690242854,0.13561268482040253,0.17436056797900054,0.08155704232786505,0.9099870749199828
NCT00000406,Bevacizumab,VEGF,vascular,0.041797507826330536,0.05116900946726662,0.022225066298474004,0.11908365851853166,0.06731414929187209,0.2683266847350155,0.9050139873104183
NCT00000407,Trastuzumab,HER2,cardiotoxicity,0.031492128384705914,0.2308492322712359,0.04937246797667403,0.02663737950700077,0.1800451237391827,0.15094474432261643,0.8884431539664307
NCT00000408,Daratumumab,CD38,infusion_reactions,0.04578022892625924,0.04764998879600295,0.07989813555600735,0.06948779831953975,0.26800256323899974,0.2887428366420012,0.8667397414201983
NCT00000409,Adalimumab,TNF-alpha,infection,0.012340693383029067,0.07600710911313908,0.04893301470438552,0.1281685338943361,0.044283390716174834,0.26498154947638797,0.9042142847854245
NCT00000410,Bevacizumab,VEGF,vascular,0.08350633134379482,0.0820233990101819,0.04989217653379062,0.061476238108165965,0.1715461599793134,0.1827175184465078,0.8948063627630409
NCT00000411,Daratumumab,CD38,infusion_reactions,0.043702490808721496,0.014005522930740387,0.02159448612066741,0.11343126211981536,0.2236368525419496,0.5372955171187188,0.8410556447265645
NCT00000412,Cetuximab,EGFR,skin_toxicity,0.11515458539316081,0.02368459722901836,0.1136411186684992,0.1297397996211263,0.1573272314097835,0.11960534499755533,0.8901412204468094
NCT00000413,Tocilizumab,IL-6,infection,0.1442679470455683,0.09540091973601696,0.042614607459865235,0.18217219154473202,0.1755214183584024,0.27343612364781245,0.8477644653679338
NCT00000414,Trastuzumab,HER2,cardiotoxicity,0.042760290298867895,0.14083596331227044,0.04752573320269382,0.020028289005083133,0.08769938615151612,0.1611514757098558,0.9166664770532855
NCT00000415,Ipilimumab,CTLA-4,immune_related,0.09674080261076407,0.07461365067468759,0.06904938137172754,0.38778272584113815,0.061844445400192675,0.11155632936243334,0.8664021107898427
NCT00000416,Tocilizumab,IL-6,infection,0.030130819434899807,0.08401971261518273,0.09410522235133088,0.16525788974584577,0.1721456980447133,0.11061576565958235,0.8906208153580741
NCT00000417,Blinatumomab,CD19/CD3,neurotoxicity,0.12008379893244817,0.06814761622034635,0.053009963073252175,0.05480683360057467,0.1534926442508785,0.06763290954065519,0.9138043723969742
NCT00000418,Trastuzumab,HER2,cardiotoxicity,0.07743501407231022,0.18286536143818571,0.04570554000182168,0.029877713755356645,0.16094824774480954,0.2388682211523016,0.8773833169725358
NCT00000419,Bevacizumab,VEGF,vascular,0.03125846824658179,0.049904321974640786,0.08394618757293917,0.15690522714662924,0.021723045869775533,0.07932300329323909,0.9294899576493657
NCT00000420,Rituximab,CD20,infusion_reactions,0.03800445316122239,0.014104488423960811,0.0539982015035395,0.09711093323840286,0.23208428686599727,0.31952888614606967,0.8741947917768013
NCT00000421,Daratumumab,CD38,infusion_reactions,0.02123780435855204,0.03971646923125854,0.04180572011141004,0.057040273308923,0.29579859190322494,0.564202465772649,0.8300331125523304
NCT00000422,Bevacizumab,VEGF,vascular,0.05779280664423827,0.03448925089429253,0.11867553483327387,0.08867030792561129,0.16257867962771935,0.07820939314905244,0.909930671154302
NCT00000423,Tocilizumab,IL-6,infection,0.07531359582861868,0.06264807168514312,0.10638665548021847,0.14445864614688683,0.14711289821541798,0.23961488323492358,0.8707442082347986
NCT00000424,Cetuximab,EGFR,skin_toxicity,0.04144867802558469,0.019274514898445946,0.1197365837580973,0.12859689230287222,0.11584751709113726,0.14063734531643352,0.9057430781012382
NCT00000425,Tocilizumab,IL-6,infection,0.13171058028187718,0.06984195496520297,0.10203800288718859,0.19338399542753337,0.08746785885888639,0.20951497686130943,0.8676737717863336
NCT00000426,Tocilizumab,IL-6,infection,0.13112341409766956,0.03521832083023525,0.08964576043612278,0.06965581449010702,0.06026732878716638,0.1769558879152493,0.906188912240575
NCT00000427,Trastuzumab,HER2,cardiotoxicity,0.03937517513847719,0.35088887419830805,0.04932346444030443,0.026647468813017668,0.06516964738789455,0.2111982978665065,0.8762328453592486
NCT00000428,Tocilizumab,IL-6,infection,0.043984190687610024,0.054547847434319056,0.07501928826953748,0.1398131277250927,0.03663447260535065,0.2452304818225295,0.9007950985759268
NCT00000429,Adalimumab,TNF-alpha,infection,0.10919407239780331,0.06046036842910689,0.10211532288952327,0.08764802120024719,0.1030346856956404,0.28131077302164775,0.8760394593943386
NCT00000430,Pembrolizumab,PD-1,immune_related,0.1073880836838125,0.05211636161465822,0.06722744276416638,0.3380799903929482,0.2408142955580007,0.13634382869479833,0.8430049995486026
NCT00000431,Rituximab,CD20,infusion_reactions,0.020572602726561307,0.04056122697550485,0.035249057938222174,0.11726093941130138,0.2807579213437524,0.3687317306258784,0.8561444201631299
NCT00000432,Rituximab,CD20,infusion_reactions,0.04543705899004646,0.03977239103313235,0.03431131173145915,0.12881363514084002,0.27044660666695675,0.4293379690152742,0.8419801712370485
NCT00000433,Tocilizumab,IL-6,infection,0.08318715471937262,0.09461773012490829,0.09944767384658951,0.13306130285553291,0.1444209235093562,0.2172670914010728,0.871333020590528
NCT00000434,Pembrolizumab,PD-1,immune_related,0.053846085685535734,0.04968509981521695,0.021931553858829302,0.38378492741799863,0.06976084007662063,0.1881004539267837,0.8721485065365024
NCT00000435,Trastuzumab,HER2,cardiotoxicity,0.06613266722847685,0.31871721027036726,0.0439772033366396,0.040281138037794186,0.17275526488163886,0.11880994491633541,0.873221095221458
NCT00000436,Tocilizumab,IL-6,infection,0.1463011388121724,0.032383097446686944,0.05906076882934628,0.028603840309472613,0.09331273162258198,0.2977439225368338,0.8904324167404843
NCT00000437,Ipilimumab,CTLA-4,immune_related,0.0894760546482479,0.06555487171740419,0.03675048146157131,0.3312426713037854,0.15945554323239164,0.09828217261363353,0.8698730341704943
NCT00000438,Tocilizumab,IL-6,infection,0.06618492219943314,0.04136852279519394,0.09970163977836355,0.17204957224406714,0.15706341754063302,0.1334408166851936,0.8883651847928526
NCT00000439,Ipilimumab,CTLA-4,immune_related,0.14246040903579604,0.06179015283555461,0.08689885197037675,0.16827127706229866,0.2157366220740008,0.06519472514931632,0.8766079936454428
NCT00000440,Cetuximab,EGFR,skin_toxicity,0.11107169339552928,0.06755065639723744,0.04442167795000948,0.10949468474913762,0.04979074329920348,0.1456740960518813,0.9119994080261669
NCT00000441,Trastuzumab,HER2,cardiotoxicity,0.02852762743769824,0.31221882585907124,0.02402375618726052,0.08447179999218529,0.18436703461572146,0.20095416927221027,0.8609061311059755
NCT00000442,Blinatumomab,CD19/CD3,neurotoxicity,0.1443031668930951,0.03904837996835604,0.022262866280055582,0.12473243039768164,0.1654128521753779,0.225057075251467,0.8798638715056611
NCT00000443,Adalimumab,TNF-alpha,infection,0.08846794069907453,0.07810935199553455,0.06920797951199033,0.09163482182714922,0.1313017738770668,0.09965490306422799,0.9069372048374927
NCT00000444,Ipilimumab,CTLA-4,immune_related,0.06358133261464413,0.0518578567656041,0.09015464405011546,0.22139112692820018,0.10267400912309504,0.15738321506250347,0.8854929692426396
NCT00000445,Trastuzumab,HER2,cardiotoxicity,0.0472979426739065,0.21902702182464068,0.046850333030593445,0.028290082123881267,0.19341124378474323,0.21291461717555588,0.8753681265644465
NCT00000446,Blinatumomab,CD19/CD3,neurotoxicity,0.13424315446457424,0.03645210329598041,0.07271174599812909,0.034798088210005546,0.1799102225599585,0.16063401368657876,0.896875111964129
NCT00000447,Trastuzumab,HER2,cardiotoxicity,0.012854098954895516,0.26439616491275686,0.0367008531071774,0.0419030636706109,0.12417393910639205,0.21664959295850855,0.8838870478816098
NCT00000448,Daratumumab,CD38,infusion_reactions,0.09849360652050201,0.01981406953189848,0.025808285629934917,0.11478950516248144,0.14319361916985615,0.2049673417115007,0.8988222620456378
NCT00000449,Pembrolizumab,PD-1,immune_related,0.08655203018105456,0.011454176753961993,0.0689776411552866,0.35137921595338706,0.1329051681702172,0.13268392309364596,0.869341307448741
NCT00000450,Trastuzumab,HER2,cardiotoxicity,0.049765999119406476,0.22369706970317224,0.043916191017201955,0.0664716490504842,0.14408826631544924,0.22772082820883793,0.8740566660975746
NCT00000451,Bevacizumab,VEGF,vascular,0.14707835163320995,0.07721135022889304,0.08774205213522691,0.19674491454299095,0.1485481736680571,0.1158893351095071,0.8711309704470191
NCT00000452,Daratumumab,CD38,infusion_reactions,0.04332056517009666,0.046002114392967766,0.075584552037935,0.08201547230807625,0.17141483437573973,0.5832364371216269,0.8330710040989263
NCT00000453,Ipilimumab,CTLA-4,immune_related,0.07017392030544119,0.07019612899364049,0.09890046340372254,0.17406860693296136,0.15765508499586356,0.06931470121810741,0.8932818490250439
NCT00000454,Cetuximab,EGFR,skin_toxicity,0.14734154349898637,0.08057967483025327,0.06581992177604831,0.10563278776679028,0.07015756500340416,0.25181339201758385,0.8797758525178223
NCT00000455,Cetuximab,EGFR,skin_toxicity,0.09457282209318442,0.07480956220143177,0.08893209894922295,0.13609387305206613,0.1086516521228284,0.2962692711948674,0.8667784533977332
NCT00000456,Trastuzumab,HER2,cardiotoxicity,0.04257005049913631,0.27227774598437565,0.012128058213066714,0.06950447525851187,0.12456994197263896,0.13723685006001257,0.8902854796687096
NCT00000457,Pembrolizumab,PD-1,immune_related,0.1929746016812942,0.021993882667631373,0.06479669836072223,0.2676988124481088,0.061509153091671515,0.1021404651663748,0.8814810644306995
NCT00000458,Cetuximab,EGFR,skin_toxicity,0.1314608007586245,0.023309211028664664,0.08502077109355739,0.03177429669985296,0.13501900705825134,0.1924384065941201,0.9001629177944882
NCT00000459,Daratumumab,CD38,infusion_reactions,0.09526160143828097,0.039110420056455424,0.05995285318673921,0.09908098163517565,0.24084356392080364,0.5770992610852622,0.8147752197795471
NCT00000460,Pembrolizumab,PD-1,immune_related,0.1979309891122349,0.02506428976599915,0.05616893786777573,0.26151871017487194,0.18493352428773208,0.09957998681727538,0.8624672603290184
NCT00000461,Daratumumab,CD38,infusion_reactions,0.06128716283930444,0.045038747938857954,0.07623874506726816,0.06442330685727317,0.20792252269413852,0.4725286918487324,0.8454268037924042
NCT00000462,Bevacizumab,VEGF,vascular,0.05402420297848261,0.010609780753999695,0.0770553878383845,0.1481804684981997,0.0773359222262474,0.0799208458040299,0.9254788986501093
NCT00000463,Ipilimumab,CTLA-4,immune_related,0.19660307735690485,0.05296953219513604,0.062381758340425156,0.3191141027835173,0.19651126741561137,0.08731992987518974,0.847516722005536
NCT00000464,Ipilimumab,CTLA-4,immune_related,0.14022882033929326,0.0631174702143022,0.034347265264832616,0.1543714278105368,0.1798814027440938,0.12424625761285475,0.8839678926690144
NCT00000465,Ipilimumab,CTLA-4,immune_related,0.0679250143451133,0.016237400819296387,0.09569177115175442,0.27220086686520717,0.23980597806774534,0.10811767109287598,0.8666702162763346
NCT00000466,Trastuzumab,HER2,cardiotoxicity,0.03853019309558235,0.3089245166057517,0.015540380134363634,0.04746362697064256,0.06437949498503884,0.12103139039488278,0.900688399635623
NCT00000467,Bevacizumab,VEGF,vascular,0.10901681319065781,0.08911580788106674,0.06496500059947963,0.05322194849618525,0.08422844076229011,0.10666005118042356,0.9154653229816495
NCT00000468,Daratumumab,CD38,infusion_reactions,0.09870724207349325,0.03532029303359043,0.03378041194096896,0.12518153868170667,0.20477345475221848,0.20816030466348306,0.8823461258090899
NCT00000469,Bevacizumab,VEGF,vascular,0.09486231974159272,0.09838091105328169,0.016506082081035593,0.08716645670822457,0.04696209788528549,0.2908999390623136,0.8942036989113777
NCT00000470,Trastuzumab,HER2,cardiotoxicity,0.04703846768200765,0.10139830781562549,0.02539014080353495,0.02221228468420396,0.1857717568815634,0.16267294045513275,0.9092526836129886
NCT00000471,Cetuximab,EGFR,skin_toxicity,0.1303102073797173,0.09601405311759834,0.030733030513025762,0.13175703145322387,0.04908587281133413,0.10459346431451731,0.9095843900684305
NCT00000472,Tocilizumab,IL-6,infection,0.058334714722448645,0.0884887385479085,0.11038760928074887,0.12794929494969765,0.11183760187259709,0.27285919159780736,0.871690474838132
NCT00000473,Tocilizumab,IL-6,infection,0.10889145924475956,0.08917047500221822,0.029524121253238313,0.04679295574564535,0.15103927188528352,0.05758541677535066,0.9194993833489173
NCT00000474,Daratumumab,CD38,infusion_reactions,0.013489685313227572,0.031503593888352374,0.07706219587888809,0.14407040113231767,0.2614409669253944,0.3246661392898336,0.8579611695953311
NCT00000475,Blinatumomab,CD19/CD3,neurotoxicity,0.050800332092408,0.04141486191356842,0.02984584357523691,0.11332799263394888,0.16403689634766766,0.17441276236094477,0.9043602185127042
NCT00000476,Bevacizumab,VEGF,vascular,0.0944904717932296,0.09976077150692973,0.11119990540380503,0.18880728722989615,0.16857703525839804,0.18699510848479367,0.8583615700538246
NCT00000477,Adalimumab,TNF-alpha,infection,0.06443841822273112,0.0503142022711113,0.02280197906164496,0.11980313205557648,0.07413503080156109,0.14142337765801954,0.9211806433215592
NCT00000478,Pembrolizumab,PD-1,immune_related,0.08591770339055403,0.06723098512257465,0.03506721484306691,0.22128540808317898,0.12166428127679851,0.18749157523625976,0.8802238053412612
NCT00000479,Bevacizumab,VEGF,vascular,0.13895745074197108,0.08298166264537069,0.1100634869378999,0.14737473827473874,0.1542499525441327,0.07469509252863778,0.8819462693878748
NCT00000480,Blinatumomab,CD19/CD3,neurotoxicity,0.08277813235471758,0.06971613398888984,0.045260837005863884,0.11492074788614665,0.1120138868119787,0.18298142053498478,0.8987214735695698
NCT00000481,Trastuzumab,HER2,cardiotoxicity,0.03759294407803299,0.26391433621167804,0.01803728350477265,0.045625313601181314,0.11718568551934058,0.08960830314898363,0.9046726889893352
NCT00000482,Bevacizumab,VEGF,vascular,0.1421946192360483,0.048368727984886076,0.057865270685235885,0.034830000015227215,0.023813464035081146,0.07607962549014853,0.9361413820922289
NCT00000483,Rituximab,CD20,infusion_reactions,0.060512769323359465,0.034386529442312914,0.03141283076132105,0.14922873585399982,0.2541481543886571,0.5083370944382322,0.8269956476320196
NCT00000484,Ipilimumab,CTLA-4,immune_related,0.15483524805506566,0.04692850908777121,0.02333060335402423,0.38403395657804795,0.11142396612777193,0.13812047885490736,0.8568878729904019
NCT00000485,Trastuzumab,HER2,cardiotoxicity,0.07301934413603875,0.26283610948925934,0.03563729712773967,0.07914056423184634,0.13014381978060652,0.059441509793353366,0.893296892573526
NCT00000486,Tocilizumab,IL-6,infection,0.05241242910836782,0.026941510972819514,0.11606058231855931,0.029438345940964675,0.15206308088799161,0.2684263010207639,0.8924429582917555
NCT00000487,Cetuximab,EGFR,skin_toxicity,0.11339561217406745,0.05715859946928824,0.029611912935689197,0.08674830647262938,0.131869298272992,0.2776655253292865,0.8839251242243412
NCT00000488,Tocilizumab,IL-6,infection,0.02381110283741894,0.09549678710634622,0.1081591684697001,0.14823390422505062,0.03167415704016038,0.10090205836161077,0.9152871369932855
NCT00000489,Daratumumab,CD38,infusion_reactions,0.028606324727856215,0.03561684567124159,0.01109148966644981,0.14220863385609442,0.1412059678142081,0.47575580810407103,0.8609191550266798
NCT00000490,Ipilimumab,CTLA-4,immune_related,0.18864683541332378,0.01033171492299218,0.03923099080299984,0.344091324318748,0.2162608077090244,0.19766029474555452,0.8339630053478929
NCT00000491,Cetuximab,EGFR,skin_toxicity,0.14819196920535121,0.0843914990168323,0.05089621552030896,0.17080171594286392,0.027161085791503174,0.08541735484963588,0.9055233599455841
NCT00000492,Pembrolizumab,PD-1,immune_related,0.08692597443807543,0.056797296390481075,0.09055558319221603,0.22685218009441133,0.16410794661964836,0.17956150684739036,0.8658665854029629
NCT00000493,Daratumumab,CD38,infusion_reactions,0.06635713702348271,0.01819505123504185,0.07150767323176224,0.1236633568359436,0.15452298731983213,0.47611250284381923,0.8482735485850197
NCT00000494,Pembrolizumab,PD-1,immune_related,0.11238310540864796,0.038954789760703025,0.042246934677740475,0.37032274124658826,0.2133449282932659,0.12323247371624278,0.8499191711494686
NCT00000495,Pembrolizumab,PD-1,immune_related,0.14001944401535732,0.05385759680328235,0.0516374778996702,0.3088005299131422,0.13982564081085957,0.1494444545613595,0.8594024759993881
NCT00000496,Pembrolizumab,PD-1,immune_related,0.08344618872239182,0.05463179385667016,0.029222272133185755,0.3706651422184484,0.14770736108198806,0.07750378422842141,0.8728039096264824
NCT00000497,Daratumumab,CD38,infusion_reactions,0.039464070834688884,0.047740124982623144,0.027954941443146794,0.11809056007491303,0.2861238638982463,0.3592818149471485,0.8535574373032055
NCT00000498,Blinatumomab,CD19/CD3,neurotoxicity,0.08507641196326503,0.035623434312609795,0.07271191670570455,0.039528569407597705,0.03910411285746841,0.25571937018185786,0.9120393640952494
NCT00000499,Trastuzumab,HER2,cardiotoxicity,0.07188185910991451,0.3850627223100582,0.03218999947501847,0.05983737719105969,0.06906725449661787,0.2491116926605928,0.855474849126123
